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CHAPTER 1: GENERAL INTRODUCTION 
Postprandial metabolism and cardiovascular diseases 
The postprandial state is a dynamic period of metabolic processes that occur following the digestion 
and absorption of a meal (Jackson et al. 2012; Burton-Freeman 2010; Lopez-Miranda et al. 2007). 
Physiologically, meal intake results in a postprandial increase in plasma glucose, serum insulin, and 
serum triglyceride concentrations. Depending on the quantity of dietary fat and carbohydrate, fatty 
acid composition, and type of carbohydrate, these metabolic events vary in extent and duration and 
can be measured for up to eight hours after a single meal intake (Jackson et al. 2012; Lacroix et al. 
2012; Calder et al. 2011). During this period, nearly every major physiological system is responding 
with compensatory and adaptive mechanisms to restore homeostasis, which, under physiological 
conditions, leads to a rapid recovery (Sottero et al. 2015; Burton-Freeman 2010). However, the 
dietary habits of Western societies, characterized by a frequent intake of energy-dense meals (≥ 3 
meals / day with less than 6 hours in-between), are responsible for the fact, that many people spend 
the majority of their day (up to 18 hours) in the postprandial state (Teeman et al. 2016a; Burton-
Freeman 2010) (Figure 1-1). Current research suggests that a chronic oversupply of macronutrients 
and total energy and the resulting prolonged and exaggerated postprandial metabolic events 
(hyperglycemia, hyperinsulinemia, and hyperlipidemia) that repeat multiple times each day, lead to 
a short-term oxidative imbalance, a status referred to as postprandial oxidative stress (Sottero et al. 
2015). In the long term, this may lead to increased susceptibility to the development of 
cardiovascular diseases (CVD) (O'Keefe and Bell 2007). 
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Figure 1-1 Extent and duration of postprandial events in the case of multiple meal consumption. Depending 
on the quantity of dietary fat and carbohydrate, fatty acid composition, and type of carbohydrate, 
postprandial events can be measured up to eight hours after a single meal intake. In the case of multiple 
meals (here: consumption of three meals every five hours), the postprandial events of the individual meals 
overlap and add up, resulting in people spending up to 18 hours in the postprandial state (own figure).  
The oxidative degradation of dietary fat and carbohydrate during energy metabolism results in 
acetyl CoA formation and the synthesis of superoxide anions in the respiratory chain in the 
mitochondria. These intermediate compounds can further react to form reactive oxygen species 
(ROS) in the cytoplasm (e.g., hydrogen peroxide or hydroxyl radicals), which have the ability to 
oxidize mitochondrial proteins, deoxyribonucleic acid, and unsaturated fatty acids (Quijano et al. 
2016; Ott et al. 2007). Moreover, this pro-oxidant state can promote non-enzymatic glycation of 
low-density lipoprotein (LDL) (Younis et al. 2008) and triggers LDL-oxidation, leading to an 
increased formation of oxidized LDL (oxLDL) (Gradinaru et al. 2015; Sies et al. 2005). The altered 
redox balance in the cells triggers the activation of numerous redox-sensitive transcription factors, 
including the nuclear factor 'kappa-light-chain-enhancer' of activated B-cells (NF-κB), which is the 
main mediator of inflammatory response (Muñoz and Costa 2013). The transcription factor NF-κB 
mediates the release of inflammatory cytokines (e.g., tumor necrosis factor α, TNF-α; interleukin-6, 
IL-6; and IL-8), and acute phase reactants like C-reactive protein (CRP), linking the food-induced 
increase in oxidative stress to a postprandial inflammatory response (Muñoz and Costa 2013). In 
endothelial cells the postprandial pro-oxidant state impacts cell function through a reduction of 
endothelial nitric oxide (NO) synthase activity and an increase in peroxynitrite formation. This 
leads to a reduced NO availability and a defective endothelial dependent vasodilation, also referred 
to as endothelial dysfunction (Gradinaru et al. 2015; Muñoz and Costa 2013). The formation of NO 
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is further impaired by the release of endothelial adhesion molecules (e.g., soluble intercellular 
adhesion molecule-1, sICAM-1; soluble vascular cell adhesion molecule-1, sVCAM-1; and soluble 
endothelial selectin, sE-selectin) through ROS-mediated endothelial activation (Lacroix et al. 2012). 
sICAM-1 and sVCAM-1 enable the adhesion and penetration of leukocytes across the vascular 
endothelium resulting in an increased recruitment of monocytes, which become macrophages by 
scavenging oxLDL. These macrophages differentiate in foam cells by accumulating lipid, initiating 
the formation of atherosclerotic plaque (Teeman et al. 2016a). Altogether, the postprandial 
metabolic response is thus associated with low-grade oxidative stress, low-grade inflammation and 
low-grade endothelial dysfunction. Figure 1-2 summarizes the events caused by postprandial 
hyperglycemia, hyperinsulinemia, and hyperlipidemia. 
 
Figure 1-2 Overview of the downstream effects mediated by nutrient overload. Excessive intake of dietary 
fat and carbohydrates leads to an increased acetyl CoA formation, which stimulates the formation of 
superoxide in the electron transport chain in the mitochondria. The subsequent conversion of superoxide to 
hydrogen peroxides results in an increase of reactive oxygen species within the cell. This change in redox 
status activates numerous redox-sensitive transcription factors, including the nuclear factor 'kappa-light-
chain-enhancer' of activated B-cells, which is the main mediator of inflammatory responses. Furthermore, 
endothelial cell function is impaired through a reduction of endothelial nitric oxide synthase activity and an 
increase in peroxynitrite formation. Modified according to (Muñoz and Costa 2013).  
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The extent and duration of all postprandial events are influenced by several meal dependent and 
meal independent factors, which are summarized in Figure 1-3. 
 
Figure 1-3 Overview of meal dependent and meal independent factors influencing postprandial metabolic, 
oxidative, and inflammatory events. Modified according to (Margioris 2009). 
The quantitative nutrient dependent factor influencing the extent and duration of postprandial events 
is the total energy content of a meal and therefore its total amount of macronutrients (Margioris 
2009). In this context, the amount of dietary carbohydrate and dietary fat is of particular 
importance, since an excessive consumption of these macronutrients results in postprandial hyper-
glycemia/hyperinsulinemia and hyperlipidemia. 
Research suggests that both for normal-weight and obese individuals an amount of 30 – 50 g of 
dietary fat seems to be required to observe a relevant increase in serum triglycerides and up to 
approximately 80 g of dietary fat the magnitude of the postprandial lipemic response seems to be 
dose-dependent (Dias et al. 2017; Lopez-Miranda et al. 2007). Regarding the fatty acid composition 
of high-fat meals (defined as >30 energy-% fat), it appears that the saturated fatty acid (SFA) 
content in particular plays an important role in the extent of the postprandial lipemic and 
inflammatory response, but the available research data are equivocal (Dias et al. 2017; Monfort-
Pires et al. 2016; Teeman et al. 2016a; Teng et al. 2015; Margioris 2009; Jackson et al. 2007). 
Furthermore, especially regarding the postprandial inflammatory response, the amount of dietary 
long chain n-3 polyunsaturated fatty acids (PUFA) like eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) are of importance, due to their potent anti-inflammatory effects. In 
contrast to the long chain n-3 PUFAs, the n-6 PUFAs (e.g., arachidonic acid) are precursors of pro-
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inflammatory mediators (e.g., series-4 leukotrienes and series-2 prostaglandins). Research suggests 
that in addition to being influenced by the fatty acid composition of the ingested meal, the 
postprandial lipemic response after a high-fat meal seems to be influenced by the fatty acid 
composition of an individual’s habitual diet as well (Dias et al. 2017; Weintraub et al. 1988). In this 
context, Weintraub and colleagues demonstrated, that a n-6 PUFA challenge following chronic 
consumption of a diet rich in n-6 PUFA resulted in a more pronounced postprandial lipemic 
response compared to the lipemic response observed following a n-3 PUFA challenge after the 
chronic consumption of a diet rich in n-3 PUFAs (Weintraub et al. 1988). 
The glycemic response to a meal is dependent on multiple factors, including meal specific (e.g., 
dose and digestibility of carbohydrate, food matrix) and metabolic factors (e.g., neuroendocrine 
responses such as the secretion and action of insulin) (Burton-Freeman 2010). Chronic 
hyperglycemia and consequently hyperinsulinemia promote insulin resistance, which represents a 
primary metabolic disturbance in the metabolic syndrome (Cordain et al. 2005; Cordain et al. 2003; 
Reaven 1995). Therefore, postprandial hyperglycemia/hyperinsulinemia are described to be 
independent risk factors for the development of CVD (Gerich 2006). Research suggests, that it is of 
special importance to avoid the occurrence of high postprandial glucose and insulin peaks, both in 
type 2 diabetic and metabolically healthy individuals, and to rather ensure a steady glucose and 
concomitant insulin release. This might protect against type 2 diabetes progression and the 
development of its associated cardiovascular complications (Heden and Kanaley 2019; Rozendaal 
et al. 2018). The glycemic load (GL), which combines the quality (glycemic index) and quantity of 
dietary carbohydrates, is an established parameter for assessing the carbohydrate quality of a meal, 
as it is better suited to predicting postprandial glucose and insulin concentrations, than the total 
amount of carbohydrates alone (Rozendaal et al. 2018). 
A major nutrient independent factor influencing postprandial events is the obese phenotype since it 
has been demonstrated that the postprandial oxidative stress response and its associated 
inflammatory and endothelial events are exaggerated and prolonged in these individuals (Telle-
Hansen et al. 2017). Since the adipose tissue releases a spectrum of inflammatory mediators, obese 
persons (BMI > 30 kg/m2) have up to 10-fold higher circulating concentrations of different 
inflammation-associated markers (e.g., CRP, TNF-α, IL-6) compared to normal-weight individuals. 
This makes a state of chronic, low-grade systemic inflammation characteristic of the overweight-to-
obese phenotype (Calder et al. 2011; Gregor and Hotamisligil 2011). According to current models it 
can be assumed that, due to their elevated inflammatory indices in the fasting state, obese 
individuals have an accentuated inflammatory response in the postprandial state as well. This seems 
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to additionally intensify the obesity-induced chronic low-grade systemic inflammation and, in the 
long run, results in a failure to recover physiological homeostasis (maladaptation) (Calder 2011; 
Margioris 2009). Research suggests that the ability of a person to metabolically adapt to food 
intake, measured by the time frame within which metabolic homeostasis recovers, can be used as an 
indicator of the persons health state (phenotypic flexibility) (Kardinaal et al. 2015; Stroeve et al. 
2015; van Ommen et al. 2014). It can therefore be assumed that the described ‘dysmetabolism’ 
characteristic for the obese phenotype contributes to its increased CVD risk (Figure 1-4). 
 
Figure 1-4 Model of the postprandial inflammatory response in normal-weight individuals (physiological 
adaptation) and obese individuals (maladaptation). Along with their already elevated inflammatory indices in 
the fasting state, obese individuals show exaggerated and prolonged postprandial inflammatory responses. In 
the long run this results in a failure to recover physiological homeostasis (= maladaptation/’dysmetabolism’), 
which leads to an increased cardiovascular disease risk. Modified according to (Margioris 2009). 
 
Zilversmit (1979) was the first to postulate the concept of atherogenesis being a postprandial 
phenomenon (Zilversmit 1979), triggered by the prolonged elevation of triglycerides in the blood 
stream and the concomitant inflammatory response in the blood vessels wall (Teeman et al. 2016a; 
Libby 2012; Ross 1999). Scientific interest in postprandial metabolic and associated oxidative, and 
inflammatory events as risk factors for CVD are still focus of current human intervention studies, 
especially considering the fact that the postprandial phase predominates over the course of a day, 
compared to the fasting state (Higgins and Adeli 2017; Burton-Freeman 2010; Tushuizen et al. 
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2005). Accumulating research suggests that even acute postprandial responses following the 
consumption of single high-carbohydrate or high-fat meals contribute to the CVD risk, with 
postprandial hyperglycemia and hyperlipidemia being independent cardio metabolic risk factors 
(Jiang et al. 2017; Jacome-Sosa et al. 2016; Nakamura et al. 2016; Pirillo et al. 2014). Therefore, 
attenuating the postprandial stress response and in this context its associated inflammatory and 
endothelial events through specific nutritional and lifestyle interventions, seems to be a promising 
approach to facilitate the recovery of metabolic homeostasis and to provide resistance to pathology. 
This might be especially relevant in the CVD risk phenotype (Teeman et al. 2016a). 
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The epidemiological concept of dietary patterns 
Over the last few decades researchers have shifted focus from the analysis of single foods or even 
nutrients to the evaluation of the effects of the whole diet and regular meals on different health 
outcomes (Hu 2002). This holistic approach takes into account the interactive, synergistic, or 
antagonistic interplay between the variety of the consumed nutrients. Furthermore, it considers the 
fact, that the physiological effect of the food matrix differs from the physiological effect of 
individual food items or nutrients (Drake et al. 2018; Gu and Scarmeas 2011; Hu 2002). In order to 
examine the joint effects of single foods and nutrients on clinical outcomes (e.g., CVD risk), the 
epidemiological concept of dietary patterns, which describe an individual’s habitual diet, gains 
scientific interest, not only in observational studies but also in controlled human intervention trials 
(Gu and Scarmeas 2011; Jacobs and Steffen 2003). The variety of differently composed dietary 
patterns allows these intervention studies to examine and evaluate the impact of different nutrient 
compositions in the context of holistic meals (realistic approach), leading to a high public health 
relevance of research results. 
Western dietary pattern 
The main dietary components of today’s Western societies comprise sizable portions of energy 
dense, nutrient poor, highly processed convenience foods such as salty snacks, sweets, and soft 
drinks, as well as animal products such as red meat, processed meats and high-fat dairy products 
(Hu 2002). Accordingly, the Western dietary pattern is characterized by a high intake of total fat 
and saturated fatty acids, as well as by a high GL, attributable to the regular consumption of large 
amounts of simple sugars (Teeman et al. 2016a; Cordain et al. 2005). Furthermore, the Western 
dietary pattern is higher in sodium and lower in potassium than plant-based dietary patterns such as 
the Mediterranean dietary pattern. Moreover, it contains a lower proportion of vitamins, minerals, 
dietary fiber, and antioxidants, which are characteristic nutrients of plant foods, particularly fruits 
and vegetables (Burton-Freeman 2010; Margioris 2009; Cordain et al. 2005). Due to its nutritional 
characteristics described above, the Western dietary pattern, which has become commonplace in 
developed countries around the world, is associated with an increased risk of developing metabolic 
and cardiovascular diseases in the long term. This is especially the case when combined with 
specific lifestyle factors (e.g., sedentary lifestyle) and genetic susceptibility (Drake et al. 2018; 
Cordain et al. 2005). 
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Mediterranean dietary pattern 
The definition of the traditional Mediterranean dietary pattern is based on the dietary habits of the 
Mediterranean countries (e.g., Greece, Spain, south Italy) in the early 1960s (Boucher 2017; Willett 
et al. 1995). It is a plant-based diet mainly characterized by the consumption of minimally 
processed, seasonally fresh, and locally grown foods of vegetable origin. These include in particular 
fruit, vegetables, legumes, nuts, and seeds. On the other hand, the traditional Mediterranean diet 
contains only limited amounts of animal foods, such as cheese, yogurt, eggs and poultry. Other 
common characteristics of this dietary pattern are a moderate consumption of red wine during 
meals, a frequent intake of fish, dependent on the proximity of the country’s distance from the 
Mediterranean Sea, and the use of olive oil as the principle source of fat (Lorgeril and Salen 2011; 
Bach et al. 2006; Willett et al. 1995; Kromhout et al. 1989; Keys et al. 1986). The described food 
selection results in a low intake of saturated fatty acids, animal protein, and sodium, as well as in a 
high intake of unsaturated fatty acids (especially oleic acid), dietary fibers, vitamins, minerals and 
polyphenols. Keys et al. were the first to associate the Mediterranean dietary pattern with different 
health benefits (Keys et al. 1986). In recent decades various observational and intervention studies 
have confirmed this assumption, demonstrating the association of the Mediterranean diet with a 
reduced risk for metabolic and cardiovascular diseases, cancer, and neurodegenerative diseases, as 
well as a reduced overall mortality (Dinu et al. 2018; Eleftheriou et al. 2018; Estruch et al. 2018; 
Sofi et al. 2014). In this context, plant foods, especially fruits and vegetables, appear to be the key 
components mainly due to their inherent antioxidant properties and potential to modulate cellular 
reductive-oxidant balance (Burton-Freeman 2010). 
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Effects of physical exercise on postprandial metabolism 
Evidence is emerging that regular aerobic exercise entails anti-inflammatory effects. Therefore, the 
integration of activity sessions into everyday life (lifestyle interventions) represents a cornerstone in 
the primary prevention of several chronic conditions such as metabolic diseases (e.g., metabolic 
syndrome), CVD (e.g., coronary heart disease), psychiatric diseases (e.g., depression), neurological 
diseases (e.g., dementia), pulmonary diseases (e.g., asthma), musculo-skeletal disorders (e.g., 
osteoporosis), and cancer (Pedersen and Saltin 2015; Flynn et al. 2007). In this context, aerobic 
activities that are rhythmic in nature like walking, jogging, biking, or swimming are particularly 
recommended, since they require all large muscle groups (Fletcher et al. 2013). Research suggests 
that a minimum of 30 minutes of moderate-intensity aerobic activity [64–76% of maximal heart rate 
(%HRmax); 46-63% of maximal oxygen uptake (VO2max)], performed on at least five days of the 
week are required to reduce the overall risk of cardiovascular events and to promote and maintain 
health throughout the age span (Fletcher et al. 2013; Garber et al. 2011; Haskell et al. 2007). Since 
this physical exercise session can be carried out either continuously or in 10-minute increments 
accumulated throughout the day, it can easily be incorporated into daily routines (e.g., walking or 
cycling to work). Furthermore, it is easy to implement and thus feasible for older, currently inactive, 
or physically more restricted individuals (Füzéki and Banzer 2018; Fletcher et al. 2013). 
Current postprandial intervention trials focus primarily on the acute impact of aerobic training 
(single exercise sessions) on postprandial hyperlipidemia, as one of the major independent 
cardiovascular risk factors (Nakamura et al. 2016; Pirillo et al. 2014). Research substantially 
suggests that acute exercise effectively attenuates the postprandial lipemic response following a 
high-fat meal when performed in the timeframe between 18 hours pre-meal, until 90 min post-meal 
(Teeman et al. 2016a). However, the majority of human intervention studies performed in 
metabolically healthy adults suggest that exercise-induced reductions in postprandial triglycerides 
are more profound if the exercise session is performed before, rather than after meal intake 
(Edinburgh et al. 2017; Haxhi et al. 2013). It appears that the effects of an exercise session on 
postprandial hyperlipidemia are measurable up to 24 hours after exercise and are mainly due to 
acute metabolic responses rather than a long-term adaptation to regular training (Plaisance and 
Fisher 2014; Katsanos 2006; Malkova and Gill 2006). 
Different possible mechanisms acting alone or in combination are discussed to be responsible for 
the exercise-induced attenuation of the postprandial lipemic response. Mechanisms include 
increased lipolysis and fatty acid oxidation in adipose tissue and skeletal muscle, increased 
clearance of intestinally derived triglyceride-rich chylomicrons from circulation and reduced 
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hepatic secretion of very-low density lipoprotein (VLDL) (Peddie et al. 2012; Malkova and Gill 
2006). An upregulation of lipoprotein lipase (LPL) expression and activity in skeletal muscle 
(stimulated by exercise) and to a lesser extent in adipose tissue (stimulated by insulin) is proposed 
to be involved in the increased clearance of postprandial triglycerides from systemic circulation 
(Plaisance and Fisher 2014; Fielding 2011). In response to exercise, the muscle LPL expression on 
the surface of the vascular endothelium appears to be increased between 4 – 8 hours post exercise 
and returns to baseline around 20 hours post exercise (Plaisance and Fisher 2014; Herd et al. 2001; 
Seip and Semenkovich 1998). In addition, the higher blood flow through the vasculature during 
exercise and thus the extended contact time between LPL and the circulating triglycerides 
contributes to increased triglyceride hydrolysis and the associated triglyceride clearance from the 
circulation (Teeman et al. 2016a; Hurren et al. 2011). Overall, the described processes lead to a 
reduction of postprandial lipidemia, of resident time of triglyceride-rich lipoproteins in the 
circulation, and of LDL oxidation. On the other hand, the concentration of serum high-density 
lipoprotein (HDL) is increased (Wang and Xu 2017; Teeman et al. 2016a; Jackson et al. 2012). At 
the same time, anti-inflammatory cytokines are released during the training session such as IL-6, 
which is produced and released by the working muscle as a myokine with anti-inflammatory 
properties (Pal et al. 2014; Pedersen and Fischer 2007). The release of IL-6 during exercise is 
transient and increases exponentially with exercise duration, returning to resting levels 
approximately 1 hour after the exercise session (Gleeson et al. 2011). IL-6 stimulates the synthesis 
of further anti-inflammatory cytokines such as IL-10 and suppresses the production of various pro-
inflammatory cytokines such as TNF-α and IL-1 (Teeman et al. 2016a; Pedersen and Fischer 2007). 
Figure 1-5 summarizes the main mechanisms that are proposed to be involved in the exercise-
induced attenuation of the postprandial lipemic and inflammatory response following a high-fat 
meal. 
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Figure 1-5 Mechanisms of exercise-induced attenuation of the postprandial lipemic response following a 
high-fat meal. Acute aerobic exercise leads to an increased TRL clearance from circulation, a decreased 
appearance of triglyceride-rich chylomicrons from the small intestine, a decreased hepatic VLDL-secretion, 
and to an increased lipolysis and fat oxidation. This results in an attenuation of postprandial lipidemia, an 
increase in serum HDL concentration, a decrease in LDL oxidation, and a decrease in TRL resident time in 
the circulation. All processes contribute to a less inflammatory environment within the vasculature through 
the release of anti-inflammatory cytokines (IL-6; IL-10) and the inhibition of pro-inflammatory cytokines 
(TNF-α; IL-1). Modified according to (Teeman et al. 2016a). HDL, High-density lipoprotein; IL, Interleukin; 
LDL, Low-density lipoprotein; TNF-α, Tumor Necrosis Factor-α; TRL, Triglyceride rich lipoproteins; 
VLDL, Very-low density lipoprotein. 
Interventional trials point out that the effect of endurance exercise on postprandial events is 
influenced by several factors related to exercise (e.g., intensity and duration) or meal characteristics 
(e.g., moderate-fat- vs. high-fat meals), as well as the time interval between them (pre- vs. post-
meal exercise) (Haxhi et al. 2013). In addition, the energy deficit created by the exercise session, 
which can be modulated equally by exercise duration and intensity, seems to be a major factor 
determining the extent to which the postprandial lipemic response is attenuated. Furthermore, an 
energy replacement of exercise energy expenditure after the training session seems to revise the 
hypolipemic effects of exercise (Plaisance and Fisher 2014; Haxhi et al. 2013; Cox-York et al. 
2012; Peddie et al. 2012). Research suggests that in metabolically healthy adults, favorable effects 
can be attained by aerobic exercise resulting in an energy expenditure of at least 500 kcal. In 
individuals with increased cardiovascular disease risk a lower energy expenditure appears to be 
sufficient to achieve similar effects (Teeman et al. 2016b; Maraki and Sidossis 2013; Cox-York et 
al. 2012; Mestek et al. 2008).  
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In addition to the modulation of the postprandial lipemic response, acute aerobic exercise is widely 
acknowledged as a strong modulator of the postprandial glycemic response as well. In this context 
aerobic exercise is recognized to increase insulin sensitivity and to improve postprandial glucose 
control (Edinburgh et al. 2017; Haxhi et al. 2013). The mechanisms involved in the exercise-
induced attenuation of postprandial glycemia are driven by an enhancement of the glucose transport 
from the circulation into the skeletal muscle. This is primarily triggered by an increased expression 
and translocation of the glucose transporter GLUT-4 from intracellular stores to the plasma 
membrane of the musculature. In this context, exercise is able to regulate different molecular 
pathways that have an additive effect on glucose uptake (Pereira et al. 2017; DiPietro et al. 2013): 
Even single exercise sessions activate the insulin signaling pathway (phosphoinositide 3-kinase 
pathway), which is the key regulator of the glucose transport into the muscle in the conditions of 
rest (insulin dependent mechanism), and further stimulate the GLUT-4 translocation via the 
contraction of skeletal muscle. The stimulation of GLUT-4 translocation via skeletal muscle 
contraction is an insulin independent glucose uptake which seems to be initiated by the release of 
calcium from the sarcoplasmic reticulum. It may involve the activation of several molecular 
signaling pathways irrespective of the exercise modality (Pereira et al. 2017; Röhling et al. 2016; 
Röckl et al. 2008; Hayashi et al. 1997). Figure 1-6 provides an overview of the postulated 
mechanisms involved in the insulin dependent and insulin independent uptake of glucose into the 
skeletal muscle. 
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Figure 1-6 Postulated insulin dependent (blue) and insulin independent (green) mechanisms involved in 
skeletal muscle glucose uptake. Insulin and muscle contractions cause translocation of the glucose 
transporter GLUT-4 to the plasma membrane initiating an increase of glucose uptake from plasma into 
muscle. Insulin stimulated GLUT-4 translocation involves the PI-3-kinase signaling pathway. The exercise-
induced GLUT-4 translocation is triggered by the release of calcium from the sarcoplasmic reticulum and is 
postulated to involve different molecular signaling pathways (e.g., AMPK, MAPK, CaMK). Modified 
according to (Pereira et al. 2017; Hayashi et al. 1997). AMPK; 5`adenosine monophosphate-activated protein 
kinase; CaMK; Ca2+/calmodulin-dependent protein kinase; GLUT-4; Glucose transporter-4; IR, Insulin 
receptor; IRS-1, Insulin receptor substrate-1; MAPK, Mitogen-activated protein kinase; P, Phosphate; PI-3K, 
Phosphatidylinositol 3-kinase. 
Human intervention trials substantially established that plasma glucose concentrations are sensitive 
to exercise timing, intensity, duration, and frequency. Research suggests that both in healthy adults 
and individuals with impaired glucose metabolism (e.g., manifested type 2 diabetes mellitus), post-
meal aerobic exercise seems to result in a greater attenuation of postprandial glycemia compared to 
exercise performed in the pre-prandial or fasted state (Borror et al. 2018; Erickson et al. 2017; 
Reynolds et al. 2016; Aadland and Hostmark 2008). The hypoglycemic effects of exercise can be 
realized immediately after just a single exercise session and thus no long-term training adaptations 
are needed for beneficial effects on blood glucose to occur (Erickson et al. 2017). The benefit of 
postprandial exercise on plasma glucose concentrations is due to the synergy between insulin and 
muscular contraction, which in combination stimulate skeletal muscle glucose uptake to a greater 
extent than either stimulus alone (Wallis and Gonzalez 2019).  
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Effects of diet and physical exercise on cognitive and emotional functioning 
The term “cognition” is a collective term combining processes and structures based on the 
recording, processing, and storing of information by the brain. A person’s cognitive abilities are 
diverse and include, among other things, perception, attention, memory, language, thinking, 
problem solving, as well as intelligence (Hänsel et al. 2016). Research substantially shows that 
cognitive capacity is strongly influenced by lifestyle modulators such as diet and physical activity 
behavior, even in individuals with genetic susceptibility for the development of Alzheimer’s disease 
(AD) (e.g., Apolipoprotein E4 carriers) (Plourde 2018; Phillips 2017). 
Numerous epidemiological studies suggest that an adherence to plant-based dietary patterns, 
especially the Mediterranean dietary pattern, is associated with improved cognitive performance, 
slower age-related cognitive decline and lower risk of cognitive impairment and neurodegenerative 
disease in older adults (Chen et al. 2019; Shannon et al. 2019; Abbatecola et al. 2018; Smith and 
Blumenthal 2016). By contrast, the number of randomized, controlled intervention trials in this field 
of research is limited (Radd-Vagenas et al. 2018). Different supplementation studies suggest an 
association between single nutrients (especially DHA) and increased cognitive performance, 
mediated by neurotrophic and neuroendocrine factors. In this context, the brain-derived 
neurotrophic factor (BDNF) and insulin-like growth factor 1 (IGF1) seem to play an important role. 
These factors regulate the transcription of genes involved in brain structure and brain function via 
different cell signaling pathways (Weiser et al. 2016; Dauncey 2009; Gómez-Pinilla 2008b). 
Furthermore, long chain n-3 PUFAs seem to modulate mood-related behaviors via the 
endocannabinoid system and the hypothalamic-pituitary-adrenal (HPA) axis (Larrieu and Layé 
2018). On the other hand, nutrients such as refined carbohydrates, saturated and trans fatty acids 
have been associated with cognitive deficits (Hawkins et al. 2018; Barnard et al. 2014). The 
neuroprotective effects of single nutrients such as DHA in the context of whole meals reflecting 
different dietary patterns (holistic approach) have not yet been sufficiently investigated and are 
examined by current ongoing human intervention trials (Bundy and Minihane 2018). 
Research reveals beneficial effects of physical activity on emotional and cognitive function and 
especially regular aerobic exercise is described to exert neuroprotective effects (Strasser and Fuchs 
2015). The cellular and molecular mechanisms that underlie the association between physical 
activity and cognition are not fully elucidated. However, regular exercise seems to affect synaptic 
plasticity and cognitive function through its involvement in neurotrophic signaling, neurogenesis, 
and the HPA axis, as well as its anti-inflammatory and anti-oxidative capacities (Phillips and 
Fahimi 2018; Mandolesi et al. 2018). Furthermore, physical exercise seems to upregulate the 
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synthesis of several neurotransmitters (e.g., serotonin, dopamine) associated with mood 
enhancement and reduced depressive symptoms (Basso and Suzuki 2017; Strasser and Fuchs 2015). 
Current research results regarding the effects of an acute session of aerobic exercise on cognitive 
performance are inconsistent with modulators of effect size being exercise intensity, temporal 
sequencing of cognitive assessment in relation to exercise (e.g., following exercise session or during 
exercise session), modality of aerobic training (e.g., cycling or running), and cognitive parameters 
measured (e.g., memory or processing speed) (Basso and Suzuki 2017; Lambourne and 
Tomporowski 2010). Postprandial intervention trials examining the interactive effects of physical 
activity and meal composition on emotional and cognitive functioning are limited (Veasey et al. 
2013; Veasey et al. 2015). However, research suggests that the effects of particular diets on the 
activation of molecular systems that are involved in synaptic plasticity and cognitive function 
interact with the effects of exercise (Gómez-Pinilla 2008b). Figure 1-7 summarizes the hypothetical 
mechanism by which the interaction of exercise and the consumption of neuroprotective nutrients 
seem to affect cognitive abilities (simplified overview). 
 
Figure 1-7 The role of specific nutrients and physical activity in maintaining mental health (simplified 
overview). Specific nutrients and physical activity show individual and additive effects on synaptic plasticity 
and cognition through the activation of different pathways: The molecules BDNF and IGF1 support synaptic 
plasticity and their activation might be triggered by energy metabolism (ATP production) in the 
mitochondria. Long-term physical activity optimizes redox homeostasis by buffering ROS formation during 
energy metabolism (anti-oxidative capacity of exercise), which helps to maintain cognitive function even 
under challenging situations. Physical activity also affects cognitive function through its role in the endocrine 
stress-regulation system (HPA axis), leading to an optimized stress response in trained individuals, 
characterized by a stronger reactivity and quicker regeneration. Modified according to (Gómez-Pinilla 
2008a; Phillips 2017). ADP, Adenosine diphosphate; ATP, Adenosine triphosphate; BDNF, Brain-derived 
neurotrophic factor; DHA, Docosahexaenoic acid; HPA, Hypothalamic-pituitary-adrenal axis; IGF1, Insulin-
like growth factor; P, Phosphate; ROS, Reactive oxygen species.   
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OBJECTIVES 
Recent postprandial intervention studies focused on the examination of the effects of aerobic 
exercise performed prior or after the consumption of high-fat or high-carbohydrate challenges on 
selected physiological parameters, in particular postprandial hyperlipidemia or hyperglycemia. 
Currently, little is known regarding the postprandial effects of exercise after the consumption of 
true-to-life meals with different nutrient composition. Also, further intervention studies are 
necessary to evaluate the efficacy of physical activity sessions of low-to-moderate intensity that can 
easily be incorporated into daily routines, even by inactive or physically more restricted individuals. 
Furthermore, only a limited number of studies address populations with higher metabolic risk, such 
as individuals with advanced age, metabolic syndrome traits and a sedentary lifestyle. Mainly for 
individuals with increased susceptibility to the development of CVD, formulating exercise-oriented 
therapeutic measures might be of special clinical importance. 
The purpose of the present study was to examine the acute postprandial effects of a 30-minutes 
moderate walking program suitably for everyday use in older subjects (60-80 years) with a risk 
phenotype for cardiovascular and neurodegenerative disease. The duration of the walking program 
was chosen to be in accordance with the current recommendations for the minimum of moderate-
intensity physical activity required on most days of the week to reduce overall risk of 
cardiovascular events and to promote and maintain health throughout the age span. In contrast to 
current postprandial intervention trials, the present study focused on the administration of realistic, 
regular meals, to be able to evaluate the joint effects of single foods and nutrients on postprandial 
events. With the purpose of examining the postprandial impact of different nutrient compositions, 
two iso-energetic meals were designed to compare common dietary patterns; the Mediterranean 
dietary pattern and the typical Western dietary pattern. Next to metabolic outcomes (lipemic and 
glycemic responses) the present study included selected oxidative (oxLDL), endothelial (sICAM, 
sVCAM, sE-selectin), and inflammatory (IL-6) parameters, with the intention of reflecting all major 
postprandial systems involved. Since only a limited number of postprandial intervention studies 
exist that focus on the interactive effects of physical activity and meal composition on 
neuropsychological parameters, additional outcome measures (attention, mood, and the feeling of 
hunger and satiety) were included in the present trial.  
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The study was performed as a randomized, controlled, crossover trial. In order to evaluate the 
interactive effects of walking and meal composition on the postprandial outcome measures, the 
participants were randomly assigned to four intervention groups, each lasting 4.5 h from morning 
until afternoon: (i) Mediterranean-type diet meal plus 30 min postprandial walking; (ii) 
Mediterranean-type diet meal plus 30 min postprandial resting; (iii) Western-diet high-fat meal plus 
30 min postprandial walking and (iv) Western-diet high fat meal plus 30 min postprandial resting.  
The study tested the following hypotheses regarding physiological outcome measures: 
1. A Mediterranean-type diet meal generates a lower postprandial response than a Western diet 
high-fat meal. 
2. Moderate walking in the postprandial period as compared to remaining sedentary, results in 
attenuated postprandial events. 
The study tested the following hypotheses regarding psychological outcome measures: 
1. A Mediterranean-type diet meal generates higher postprandial satiety, postprandial attention, 
and a better subjective mood than a Western diet high-fat meal. 
2. Moderate walking in the postprandial period as compared to remaining sedentary, results in 
increased postprandial attention and a better subjective mood. 
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ABSTRACT 
Background: Research suggests that postprandial events as risk factors for cardiovascular diseases 
(CVD) are influenced by meal composition and exercise. 
Objective: We investigated the effect of walking versus rest on postprandial metabolic, 
inflammatory, and oxidative events following the consumption of test meals reflecting two different 
dietary patterns in older adults with increased CVD risk. 
Design: A randomized crossover trial was conducted in 26 men and women (age 70±5 y; BMI 30.3 
± 2.3 kg/m2). Each adult participated in four treatments combining one of two isoenergetic 
(4300 kJ) meals [Western diet high-fat meal (WD): total fat, 59.4 g; saturated fatty acids, 32.0 g, 
dietary fiber, 4.2 g; Mediterranean-type diet meal (MD): total fat, 40.1 g; saturated fatty acids, 5.1 
g; dietary fiber, 14.5 g] with 30 min walking (4.6 ± 0.1 km/h) or rest. Primary (serum triglycerides) 
and secondary (serum non-esterified fatty acids, NEFAs; parameters of glucose metabolism, 
inflammation, endothelial activation, oxidation; blood pressure/heart rate) outcomes were measured 
at fasting and 1.5, 3.0, 4.5 h postprandially. Data were analyzed by linear mixed models.  
Results: Triglycerides were higher after WD compared to MD (AUC in mmol/L x min: WD-W 218 
± 15.2; WD-R 207 ± 12.6; MD-W 139 ± 9.83; MD-R 149±8.15, P<0.001). No meal or activity 
effect was observed for NEFAs based on AUC data (WD-W -43.5 ± 7.08; WD-R -49.2 ± 6.94; MD-
W -48.0 ± 11.6; MD-R -67.6 ± 7.58). Plasma glucose was higher after MD compared to WD (WD-
W 222 ± 34.9; WD-R 177 ± 32.8; MD-W 314 ± 44.4; MD-R 275 ± 57.8, P<0.001), as was serum 
insulin (AUC in ng/mL x min: WD-W 82.0 ± 10.3; WD-R 88.6 ± 12.8; MD-W 129 ± 14.7; MD-R 
138 ± 20.5, P<0.001). Plasma interleukin-6 was higher after walking compared to resting (AUC in 
pg/mL x min: WD-W 72.0 ± 34.0; WD-R 14.3 ± 38.8; MD-W 70.8 ± 39.4; MD-R 5.60 ± 26.0, 
P<0.05). Plasma vitamin C was higher after MD compared to WD (P<0.001) and after walking 
compared to resting (P<0.05) (AUC in mg/L x min: WD-W -305 ± 59.6; WD-R -396 ± 84.0; MD-
W 113 ± 56.4; MD-R -44.5 ± 48.1). We observed no meal or activity effects on parameters of 
oxidation and endothelial adhesion molecules. Our data revealed no significant meal x activity 
effects on all outcomes. 
Conclusions: In older adults with increased CVD risk, the MD was associated with superior effects 
on several postprandial parameters (e.g., triglycerides) in comparison to the WD. Data revealed no 
relevant differences regarding the effects of post-meal walking and resting. None of the four 
treatments can be rated as superior regarding their acute effects on the shown postprandial 
metabolic, oxidative, and inflammatory parameters. 
The trial was registered at German Clinical Trials Register (DRKS) (http://www.germanctr.de and 
http://www.drks.de) under identifier DRKS00012409.  
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INTRODUCTION 
The postprandial state is the dynamic period of metabolic processes that occur following the 
digestion and absorption of a meal (1–3). In developed societies, modern lifestyle is characterized 
by an excessive food intake. As a result, many individuals spend the majority of their waking hours 
in the postprandial state, and experience exaggerated and prolonged postprandial metabolic 
(lipemia, glycemia/insulinemia), oxidative, and immune imbalances. This phenomenon is termed 
“postprandial oxidative stress”. This prolonged pro-oxidative phase is accompanied by postprandial 
low-grade inflammation and impaired endothelial function, and can promote cellular dysfunction 
and cardiovascular disease (CVD) (1, 2). Scientific interest in postprandial metabolic events as risk 
factors for CVD is therefore increasing (4). 
The magnitude and duration of postprandial responses is influenced by the quantity and quality of 
macronutrients in the consumed meal (2, 3). In contrast to the dietary pattern which is typically 
consumed in Western societies [high in total fat, saturated fatty acids (SFAs), simple carbohydrates 
and animal protein; low in dietary fiber, vitamins and minerals] (5, 6), the Mediterranean dietary 
pattern has been consistently associated with a lower CVD risk (7–13). Research suggests that these 
effects are attributable to the high-quality food choices (plant-based, minimally processed) and 
characteristic nutrients (e.g., antioxidants such as vitamins, polyphenols and n-3 PUFAs) of this 
eating pattern (11). 
Independent of meal composition, postprandial metabolic events show wide inter-individual 
variation. For example, aging, physical activity status and metabolic status seem to affect 
postprandial metabolic responses (14). In addition to elevated inflammatory indices in the fasting 
state, overweight-to-obese patients with metabolic syndrome and insulin resistance show 
accentuated postprandial inflammatory responses compared to metabolically healthy, normal weight 
individuals (15, 16), which likely contributes to their increased CVD risk. This emphasizes the 
importance of attenuating postprandial metabolic events via lifestyle interventions, particularly in 
this high risk population (17). Current international guidelines recommend regular physical activity 
to lower CVD risk and previous studies suggest that even acute bouts of exercise have beneficial 
effects on cardio-metabolic risk factors (17, 18). Research has shown that the postprandial effects of 
a bout of exercise are influenced by several modulators. These include mode of exercise (aerobic or 
resistance), duration and intensity of exercise, total energy expenditure, meal composition, and the 
exercise meal sequence (pre- or post-meal exercise) (18). To date, the majority of studies have 
focused on the acute effect of a single bout of exercise (in particular aerobic exercise) on 
postprandial lipemia in metabolically healthy adults (19). To our knowledge, no previous human 
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study has investigated the acute effects of postprandial exercise suitable for daily implementation 
on metabolism following the consumption of meals reflecting different dietary patterns. 
Therefore the aim of the present study was to determine the acute impact of dietary pattern and 
moderate walking on postprandial metabolic, inflammatory, and oxidative events in older adults 
with a CVD risk phenotype. In this context, the focus was set especially on the interactive effects of 
meal composition and postprandial activity behavior on these postprandial outcomes. The effects on 
serum triglycerides (postprandial lipemia) were the primary outcome measure, whereas all other 
parameters [serum non-esterified fatty acids (NEFAs), parameters of glucose metabolism, 
inflammation, endothelial activation, oxidation and blood pressure] were secondary outcome 
measures. The study tested two hypotheses: i) a Mediterranean-type diet meal (MD) generates a 
lower postprandial response than a Western diet high-fat meal (WD); and ii) acute postprandial 
walking has a more beneficial effect on postprandial parameters than a period of postprandial rest. 
  
32  CHAPTER 2: MANUSCRIPT 1 
 
 
MARTERIALS AND METHODS 
Participants 
Between April 2017 and May 2017 volunteers (n=31) aged 60 to 80 y from Bonn (Germany) and 
the surrounding area attended a one hour screening session at the Department of Nutritional 
Physiology at the University of Bonn to determine eligibility for the present study. The screening 
session was conducted in the fasting state and comprised documentation of medical history and 
dietary habits, physical assessments (measurement of height, weight, fat mass, waist and hip 
circumference, resting blood pressure and heart rate) and clinical biochemistry and hematology 
assessments (liver and kidney function, serum lipids and lipoproteins, plasma glucose, high 
sensitivity C-reactive protein (hs-CRP), and hematology profile). The main study inclusion criteria 
were: i) excessive body weight or obesity stage 1 (BMI 27-34.9 kg/m2), ii) visceral fat distribution 
(waist circumference ≥94 cm for men and ≥80 cm for women), and iii) prehypertension (≥120–139 
mmHg systolic and/or ≥80–89 mmHg diastolic) or stage 1 hypertension (≥140–159 mmHg systolic 
and/or ≥90–99 mmHg diastolic). In addition, study eligibility required fulfillment of at least one of 
the following criteria: i) dyslipidemia (fasting serum triglycerides ≥1.7 mmol/L and/or serum HDL-
cholesterol <1.0 mmol/L for men and <1.3 mmol/L for women), ii) increased plasma glucose 
(fasting plasma glucose ≥5.6 mmol/L) or iii) a pro-inflammatory state (hs-CRP ≥2.0 mg/L) (20, 21). 
The main exclusion criteria were: malabsorption syndromes, unmedicated thyroid disease, impaired 
kidney function, secondary hypertension, chronic liver diseases, heart insufficiency and prior 
myocardial infarction, insulin-treated Diabetes mellitus and untreated Diabetes insipidus, chronic 
inflammatory disease including rheumatoid arthritis, tumor diseases, immobility or use of walking 
aid, alcohol or medicine abuse, chronic intake of dietary-supplements and immune suppression 
medication. 
A total of 26 adults (18 male and eight female) were included in the trial. All participants completed 
the entire postprandial study, and the respective data were included in the analysis. Participant flow 
from initial screening to final analysis is shown in Figure 2-1. Baseline characteristics are presented 
in Table 2-1. The study was conducted in accordance with the principles of the 1964 Declaration of 
Helsinki and its later amendments. All study procedures were approved by the ethics committee of 
the Medical Faculty of the Rheinische Friedrich-Wilhelms-University of Bonn, Germany. Written 
informed consent was obtained from all adults prior to inclusion. The trial was registered at German 
Clinical Trials Register (DRKS) (http://www.germanctr.de and http://www.drks.de) under identifier 
DRKS00012409. 
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Figure 2-1 Flow chart of process of eligibility assessment, enrollment, and allocation. MD-R, 
Mediterranean-type diet meal plus postprandial resting; MD-W, Mediterranean-type diet meal plus 
postprandial walking; WD-R, Western diet high-fat meal plus postprandial resting; WD-W, Western diet 
high-fat meal plus postprandial walking.  
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Table 2-1 Baseline characteristics of participants at high risk of cardiovascular disease1 
 Total 
(n = 26) 
Female 
(n = 8) 
Male 
(n = 18) 
 
P-value2  
Age (y) 69.9 ± 4.7 69.4 ± 5.6 70.8 ± 4.8 0.519 
Height (cm) 171.4 ± 8.4  161.0 ± 5.0 176.0 ± 5.0 <0.001 
Body weight (kg) 88.8 ± 8.2 82.2 ± 8.7 91.8 ± 6.1 0.003 
BMI (kg/m2) 30.3 ± 2.3  31.6 ± 3.0 29.7 ± 1.7 0.047 
Body fat (%) 38.4 ± 8.1 40.6 ± 5.2 33.6 ± 3.7 <0.001 
Waist circumference (cm) 104 ± 5.8 99.8 ± 7.5 106 ± 4.0 0.069 
Hip circumference (cm) 106 ± 5.4 110 ± 6.2 105 ± 4.4 0.029 
Waist-to-height ratio 0.61 ± 0.03  0.62 ± 0.04 0.60 ± 0.03 0.176 
Systolic blood pressure (mmHg) 149 ± 16.4 150 ± 17.8 149 ± 16.4 0.982 
Diastolic blood pressure (mmHg) 88.3 ± 7.3  91.3 ± 8.2 87.0 ± 6.8 0.184 
Heart rate (min-1) 63.7 ± 8.9 65.8 ± 9.0 62.8 ± 8.8 0.453 
Serum triglycerides (mmol/L) 1.76 ± 0.79 1.98 ± 0.64 1.67 ± 0.85 0.375 
Serum total cholesterol (mmol/L) 4.86 ± 1.60 4.92 ± 0.89 5.23 ± 1.03 0.464 
Serum HDL cholesterol (mmol/L) 1.61 ± 0.37 1.64 ± 0.22 1.60 ± 0.42 0.769 
Serum LDL cholesterol (mmol/L) 3.19 ± 0.76 3.09 ± 0.59 3.23 ± 0.83 0.675 
Plasma glucose (mmol/L) 5.64 ± 0.66 5.90 ± 1.02 5.52 ± 0.42 0.328 
Serum hs-CRP (mg/L) 2.5 ± 3.0 2.7 ± 1.6 2.4 ± 3.4 0.833 
1Shown as mean ± SD, n = 26. 
2compared using independent samples t tests. 
hs-CRP, high sensitivity C-reactive protein. 
Study protocol 
A randomized controlled crossover trial was performed at the Department of Nutritional Physiology 
(University of Bonn, Germany) from June 2017 until August 2017. All adults participated in four 
treatment conditions, each lasting 4.5 h from morning until afternoon. Study days were separated by 
2 wk wash-out periods. The order of treatments was randomized for each subject via computer 
generated randomization tables (Microsoft Excel). The four treatment conditions were as follows: 
(i) MD plus 30 min postprandial walking (MD-W); (ii) MD plus 30 min postprandial resting (MD-
R); (iii) WD plus 30 min postprandial walking (WD-W) and (iv) WD plus 30 min postprandial 
resting (WD-R). Venous blood sampling and measurements of blood pressure and heart rate were 
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taken at fasting (0 h) and 1.5, 3.0 and 4.5 h postprandially. The participants were instructed to 
maintain their habitual diet, body weight, body composition, and lifestyle across the entire study 
period. For the 24 h period prior to each treatment, the participants were instructed to abstain from 
alcohol and intense physical activity. For the purpose of standardization, the participants were also 
instructed to complete a 1-day food diary and activity log on the day prior to each treatment in order 
to monitor and identify possible variations in total energy intake, total intake of macronutrients, and 
physical activity level (PAL). Participants taking antihypertensive (n=19), lipid lowering (n=11), or 
thyroid (n=8) drugs were instructed to continue taking their medication throughout the study period 
as prescribed by their physician. 
Test meals 
The WD and MD test meals (challenges) were designed specifically for the purposes of the present 
study. The food items and nutrient composition of the test meals were based on published data on 
average nutrient profile and most commonly consumed foods in the respective dietary patterns (5, 6, 
11, 12). Furthermore, the food selection focused on food items usually consumed in Germany. The 
main components of the WD were croissants, bread rolls, jam, butter, cold cuts, boiled eggs and 
cream yogurt. The main components of the MD were ciabatta, smoked salmon, muesli, fruit, and 
vegetables. Canola oil was used in the MD, since it has a similar fatty acid composition (except for 
alpha-linolenic acid), but a more neutral flavor than olive oil. The food items per serving WD and 
MD are summarized in Table 2-2 and Table 2-3. The meals were designed to be iso-energetic 
(4300 kJ per meal) and iso-nitrogenous. The WD was rich in total fat, SFAs, and animal protein. 
The MD was rich in unsaturated fatty acids, dietary fiber, and antioxidative compounds. The 
nutrient composition of the test meals were calculated by using the computer-based nutrient 
calculation program EBISpro based on the German nutrient database Bundeslebensmittelschlüssel, 
version 3.01 (Max Rubner-Institut) (Table 2-4). Both test meals were prepared at the study location 
by study personnel in accordance with a standardized protocol, which included the weighing of 
each food component to the nearest gram. During each meal, the participants consumed a glass of 
water. The participants were required to ingest the complete test meal within 20 min, under the 
observation of study personnel. 
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Table 2-2 Food items per serving of Western diet high-fat test meal 
Food items Amount (g) 
Croissant 60 
Bread roll 45 
Butter 10 
Strawberry jam 35 
Cold cuts 50 
Egg (chicken) 40 
Cream yogurt (10% fat),  
strawberry flavor  
150 
 
Table 2-3 Food items per serving of Mediterranean-type diet test meal 
 
 
 
 
 
 
 
 
 
 
 
1Main components were apple, orange, carrot, lemon, banana and sweet potatoe. 
2Main components were oats, walnut, hazelnut, yogurt, honey, and apple. 
3Main components were lentils, olives, tomato paste, pine nuts, rosemary, and lemon juice. 
4Incorporated into smoothie, lentil spread and ciabatta.  
 
 
 
 
 
Food items Amount (g) 
Smoothie1 290 
Muesli2 178 
Lentil spread3 41.5 
Ciabatta bread 135 
Smoked salmon 20 
Cucumber 30 
Tomato 30 
Basil (fresh) 0.5 
Kiwi fruit 50 
Canola oil4 18 
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Table 2-4 Nutrient composition per serving of the two test meals1 
 
Western diet  
high-fat meal 
Mediterranean-type 
diet meal 
Energy (kJ) 4247 4251 
Carbohydrates (g) 93.7  133 
Mono- and disaccharides (g) 45.0 51.0 
Polysaccharides (g) 47.0  78.9 
Ratio mono- and disaccharides to polysaccharides 0.96 0.65 
Dietary fiber (g) 4.2 14.5 
Protein (g) 26.1  25.9 
Total fat (g) 59.4 40.1 
SFAs (g) 32.0  5.1 
MUFAs (g) 19.7 20.0 
n-6 PUFAs (g) 3.4 8.0 
n-3 PUFAs (g) 0.7  2.9 
Total EPA, DPA, DHA (g) 0.0 0.6 
Cholesterol (mg) 306 14.4 
ß-carotene (mg) 0.2 5.4 
Vitamin A1 (µg) 365 902 
Vitamin E2 (mg) 2.3 12.1 
Vitamin C (mg) 9 102 
1Retinol equivalent. 
2-Tocopherol equivalent. 
EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; MUFA, 
monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; SFA, saturated fatty acid. 
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Physical activity 
The assigned activity (walking or resting) was performed immediately after the consumption of the 
test meal. The 30 min walking program was performed outdoors on the University of Bonn campus 
in the company of study personnel. The 30 min duration was selected to reflect current 
recommendations for the minimum level of moderate-intensity physical activity required on most 
days of the week to reduce the risk of CVD events (22). During the first walking treatment, the 
participants were instructed to walk at a moderate pace, corresponding to their individual speed of 
comfort. For standardization purposes, this speed was then reproduced during the second walking 
session. For each participant, walking speed and distance were measured by study personnel using a 
measuring wheel (Berlan Measuring Wheel) equipped with a tachometer (Sigma BC 8.12). In 
addition, the number of steps was recorded using a pedometer (Omron walking style IV), while 
heart rate was measured using a heart rate monitor (Polar watch FT1). To classify and compare the 
metabolic state of the participants immediately after each walking session, the plasma lactate 
concentration in peripheral blood was measured by study personnel using a quick, commercially 
available test (Lactate SCOUT+). Perceived exertion was rated using the Borg Rating of Perceived 
Exertion scale (23). The resting (control) phase took place at the study location. The subject 
remained in a supine position, and was instructed to abstain from talking, reading, or sleeping for 30 
min. 
Measurements 
Blood pressure and heart rate 
Blood pressure and heart rate were measured twice under standardized conditions using an 
automatic blood pressure measurement device (Boso Carat Professional), in accordance with the 
recommendations of the American Heart Association Council on High Blood Pressure Research 
(24, 25). 
Anthropometrics 
All anthropometric measurements were obtained during screening for study eligibility. Body 
composition (fat mass and fat-free mass) was determined by air-displacement plethysmography 
using the BOD POD body composition system (Cosmed). Height was determined to the nearest 0.1 
cm using a stadiometer (Seca scale 704). Waist circumference was measured midway between the 
lowest rib and the iliac crest with the subject at minimal respiration. Hip circumference was 
measured at the height of the greater trochanters.  
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Blood sample processing and analysis 
Fasting and postprandial blood samples were taken using tubes containing EDTA, fluoride, or a 
coagulation activator (Sarstedt). Plasma and serum were obtained by centrifugation at 3000 g for 15 
min at 8°C. Aliquots of plasma and serum were immediately frozen and stored in cryovials at - 
80°C until analysis for NEFAs, parameters of endothelial activation, inflammation, and oxidation. 
Fasting and postprandial triglycerides, insulin, and glucose (study data), as well as serum 
cholesterol, clinical biochemistry and hematology parameters, and hs-CRP (screening data), were 
assayed within 4 h of blood sampling.  
Serum concentrations of triglycerides, total cholesterol, LDL-cholesterol, and HDL-cholesterol 
were measured using VIS photometry (cobas 8000 modular analyzer series, Roche Diagnostics).  
Plasma concentration of glucose was measured using the enzymatic reference method with 
hexokinase and VIS photometry (cobas 8000 modular analyzer series). Serum insulin concentration 
was measured using a chemiluminescent immunometric assay (cobas 8000 modular analyzer 
series). Serum concentration of hs-CRP was determined using a turbidimetric immunoassay (cobas 
8000 modular analyzer series). 
Hematological parameters were determined by fluorescence flow cytometry, photometry, and the 
resistance measuring technique using a hematology analysis device (Sysmex XN9000, Sysmex 
XN1000 analyzer). Serum alanine transaminase, aspartate transaminase, gamma-glutamyl 
transpeptidase, and serum concentration of total bilirubin were measured using VIS photometry 
(cobas 8000 modular analyzer series). Serum creatinine was determined using the Jaffé bichromatic 
kinetic method (cobas 8000 modular analyzer series).  
Serum concentration of NEFAs was analyzed in duplicate using an in vitro enzymatic colorimetric 
method assay (NEFA-HR(2), Wako Diagnostics).  
Plasm/serum concentration of soluble endothelial selectin (sE-selectin), soluble intercellular 
adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), high 
sensitivity interleukin-6 (IL-6) (R&D systems), and oxidized LDL (oxLDL) (Immundiagnostik AG) 
were determined in duplicate using commercially available enzyme-linked immunoassay kits.  
The antioxidant capacity of plasma was measured as trolox equivalent antioxidant capacity 
(TEAC), in accordance with Miller et al. (26). Plasma retinol, α-tocopherol, and β-carotene were 
measured as described previously (27). For vitamin C analysis, metaphosphoric acid was added to 
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plasma samples for stabilization purposes. After centrifugation, the supernatant was poured into 
vials and analyzed using HPLC with ultraviolet detection.  
 
Sample size calculation 
Sample size was calculated a priori based on serum triglyceride concentration as primary outcome 
measure. Triglyceride data from a previous postprandial trial of similar design conducted in our 
research group (Schönknecht YB, Crommen S, Stoffel-Wagner B, Coenen M, Fimmers R, Stehle P, 
Egert S: unpublished results) and anticipated postprandial changes in triglycerides in the four 
treatment conditions (one sample t test; 2-sided; P<0.05) were used for calculation. The sample size 
calculation indicated that a minimum of n=24 individuals would provide a power of 80% to detect a 
difference of 0.14 mmol/L, assuming a standard deviation (SD) for the difference of 0.23 mmol/L. 
To account for a potential drop-out rate of 10%, a total of 26 participants were included. 
Statistical analysis 
All statistical analyses were performed using the IBM SPSS statistical software package (SPSS 
version 25, IBM Corporation, Somers, USA). Baseline characteristics of male and female adults 
(screening data) were compared using independent samples t tests.  
To identify differences in total energy- and macronutrient intake (as recorded in the 1-day food 
diaries) and PAL (as recorded via the physical activity logs) between the four pre-treatment days, 
the data were compared using one-way ANOVA (Table 2-5, Table 2-6).  
To compare the parameters measured during walking (heart rate, number of steps, distance, speed, 
lactate concentrations, and perceived exertion) after WD and MD, one- sample t tests were used 
(Table 2-7).  
The linear mixed-models procedure was used to test the effects of the intervention (meal and 
activity), time points, and their interaction on all postprandial parameters (blood pressure, heart rate 
and blood parameters). Fixed factors comprised: meal type (WD and MD); activity (walking and 
resting); time points (1.5, 3.0 and 4.5 h postprandially); and interactions (meal x activity, meal x 
time, activity x time, and meal x activity x time). Subject identifier was set as a random factor. The 
respective baseline values (fasting measures) of the postprandial parameters were included as 
covariates in the corresponding tests. Furthermore, in all tests, the residuals were checked for 
relevant deviations from a normal distribution. In case of a significant interaction between meal and 
activity (meal x activity), the linear mixed models procedure was conducted separately for WD and 
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MD to demonstrate possible activity effects for both meals. Also, all postprandial time points were 
analyzed separately, to check for possible meal, activity, and meal x activity effects on each time 
point. Furthermore, incremental area under the curve (iAUC) was calculated for selected blood 
parameters (e.g., glucose and insulin) using the trapezoidal rule, and the linear mixed-models 
procedure was used to test meal, activity, and meal x activity effects. In all analyses, the 
significance level was set at P<0.05. Unless otherwise stated, descriptive data are presented as the 
arithmetic mean ± standard error of the mean (SEM). 
RESULTS 
Baseline characteristics 
Baseline characteristics of the participants are presented in Table 2-1. All participants were 
overweight (46.2%) or obese (53.8%), had a visceral fat distribution, and were prehypertensive or 
displayed stage 1 hypertension. Significant sex differences were found for height, body weight, 
BMI, hip circumference, and body fat mass (P<0.05). 
One-day food diaries and physical activity logs 
For all participants, no significant difference was found in total energy and macronutrient intake 
and PAL between the four pre-treatment days. As instructed, the PAL data indicated that all 
participants had refrained from strenuous physical activity (mean PAL of 1.4) (Table 2-5, Table 2-
6).  
Table 2-5 Energy- and macronutrient intake of participants at high risk of cardiovascular disease before each 
treatment day1 
 
V 1 V 2 V 3 V 4 P-value2 
Energy (kcal) 1771 ± 427 1906 ± 551 1874 ± 492 1837 ± 499 0.783 
Fat (g) 79.9 ± 34.9 85.0 ± 34.4 86.3 ± 32.1 82.2 ± 34.2 0.908 
Carbohydrate (g) 166 ± 39.3 179 ± 57.1 176 ± 53.4 173 ± 57.1 0.839 
Protein (g) 70.5 ± 21.6 75.1 ± 29.7 71.0 ± 25.1 70.8 ± 21.0 0.895 
1Data from 1-d food diaries; Shown as mean ± SD, n = 26. 
2Compared using one-way ANOVA. 
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Table 2-6 Physical activity level of participants at high risk of cardiovascular disease before each treatment 
day1 
 
V 1 V 2 V 3 V 4 P-value2 
PAL 1.40 ± 0.14 1.38 ± 0.21 1.37 ± 0.20 1.38 ± 0.19 0.923 
1Data from 1-d physical activity logs; Shown as mean ± SD, n = 26. 
2Compared using one-way ANOVA. 
PAL; physical activity level. 
Parameters measured during walking 
For all participants, no significant difference was found between the two meal types in terms of 
parameters recorded during postprandial walking (heart rate, number of steps, distance, speed, 
lactate concentration, perceived exertion), indicating that physical stress was standardized across 
both walking sessions. Plasma lactate analysis indicated that the walking session represented a 
moderate bout of physical activity. Plasma lactate concentrations were 1.87 ± 0.49 mmol/L after 
WD-W, and 2.04 ± 0.57 mmol/L after MD-W. Ratings of perceived exertion were 12.1 ± 1.49 after 
WD-W and 12.0 ± 1.62 after MD-W. These scores indicate a rating of “moderately strenuous” 
(Table 2-7). 
Table 2-7 Comparison of all parameters recorded during the walking sessions in participants at high risk of 
cardiovascular disease1 
 WD-W MD-W P-value2 
Number of steps 3428 ± 201 3441 ± 243 0.803 
Distance (km) 2.33 ± 0.25 2.35 ± 0.25 0.857 
Speed (km/h) 4.62 ± 0.49 4.62 ± 0.49 0.991 
Heart rate (min-1)3 100 ± 12.2 97.8 ± 10.9 0.498 
%Heart ratemax (%) 63.6 ± 7.72 62.2 ± 6.73 0.490 
Plasma lactate concentration (mmol/L) 1.87 ± 0.49 2.04 ± 0.57 0.237 
Perceived exertion (points)4 12.1 ± 1.49 12.0 ± 1.62 0.860 
1Shown as mean ± SD, n = 26.  
2Compared using independent sample t tests. 
3Mean heart rate during walking unit. 
4Borg-RPE scale. Shown scores indicate moderate exertion. 
MD-W, Mediterranean-type diet meal plus postprandial walking; WD-W, Western diet high-fat meal plus 
postprandial walking. 
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Serum lipids, glucose, and insulin 
Serum triglycerides concentrations were higher after WD compared to MD (P<0.001). No activity 
effect was found for this parameter (Figure 2-2). Comparison of AUCs showed a significant effect 
for meal type (P<0.001) (AUC in mmol/L x min: WD-W 218 ± 15.2; WD-R 207 ± 12.6; MD-W 
139 ± 9.83; MD-R 149±8.15).  
 
 
Figure 2-2 Fasting (0 h) and postprandial (1.5, 3.0, 4.5 h) serum triglyceride concentrations in the four 
treatments in participants at high risk of cardiovascular disease. Mean ± SEM, n = 26. ***P<0.001, 
**P<0.01 meal effect for specific time point. MD-R, Mediterranean-type diet meal plus postprandial resting; 
MD-W, Mediterranean-type diet meal plus postprandial walking; WD-R, Western diet high-fat meal plus 
postprandial resting; WD-W, Western diet high-fat meal plus postprandial walking. 
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Concentrations of serum NEFAs were higher after WD compared to MD (P<0.001), and after 
walking compared to resting (P<0.001) (Figure 2-3). Comparison of AUCs showed no effect for 
meal or activity (AUC in mmol/L x min: WD-W -43.5 ± 7.08; WD-R -49.2 ± 6.94; MD-W -48.0 ± 
11.6; MD-R -67.6 ± 7.58). 
 
 
Figure 2-3 Fasting (0 h) and postprandial (1.5, 3.0, 4.5 h) serum NEFA concentrations in the four treatments 
in participants at high risk of cardiovascular disease. Mean ± SEM, n = 26. ***P<0.001 meal effect for 
specific time point. §§§P<0.001, §P<0.05 activity effect for specific time point. MD-R, Mediterranean-type 
diet meal plus postprandial resting; MD-W, Mediterranean-type diet meal plus postprandial walking; NEFA, 
non-esterified fatty acid; WD-R, Western diet high-fat meal plus postprandial resting; WD-W, Western diet 
high-fat meal plus postprandial walking 
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For plasma glucose a significant effect was found for meal but not for activity. Here, concentrations 
were higher after MD compared to WD (P=0.002). In addition, a significant interaction for activity 
x time (P=0.015) and meal x time (P=0.033) was observed: At 1.5 h postprandially, glucose 
concentrations were higher after walking for both meal types (P<0.001). At 3.0 h postprandially, no 
activity effect was observed. However, a significant effect was found for meal type (higher glucose 
concentrations after MD; P=0.003). No treatment effects were found at 4.5 h postprandially (Figure 
2-4). Statistical analysis of AUC values revealed an effect for meal type (P<0.001) (AUC in 
mmol/L x min: WD-W 222 ± 34.9; WD-R 177 ± 32.8; MD-W 314 ± 44.4; MD-R 275 ± 57.8). 
 
 
Figure 2-4 Fasting (0 h) and postprandial (1.5, 3.0, 4.5 h) plasma glucose concentrations in the four 
treatments in participants at high risk of cardiovascular disease. Mean ± SEM, n = 26. ***P<0.001, 
**P<0.01 meal effect for specific time point. §§§P<0.001 activity effect for specific time point. MD-R, 
Mediterranean-type diet meal plus postprandial resting; MD-W, Mediterranean-type diet meal plus 
postprandial walking; WD-R, Western diet high-fat meal plus postprandial resting; WD-W, Western diet 
high-fat meal plus postprandial walking. 
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Serum insulin concentrations were higher after resting compared to walking (P=0.021), and after 
MD compared to WD (P<0.001). As for glucose data, analysis of the insulin data revealed a 
significant activity x time and meal x time interaction. At 1.5 h postprandially, a meal effect only 
was observed, with higher concentrations after MD (P<0.001). At 3.0 h postprandially, insulin 
concentrations were higher after resting for both meals (P<0.001). No meal or activity effects were 
seen at 4.5 h postprandially (Figure 2-5). Statistical analysis of AUC values showed an effect for 
meal type (P<0.001) (AUC in nmol/L x min: WD-W 82.0 ± 10.3; WD-R 88.6 ± 12.8; MD-W 129 ± 
14.7; MD-R 138 ± 20.5). 
 
 
Figure 2-5 Fasting (0 h) and postprandial (1.5, 3.0, 4.5 h) serum insulin concentrations in the four treatments 
in participants at high risk of cardiovascular disease. Mean ± SEM, n = 26. ***P<0.001, **P<0.01 meal 
effect for specific time point. §§§P<0.001 activity effect for specific time point. MD-R, Mediterranean-type 
diet meal plus postprandial resting; MD-W, Mediterranean-type diet meal plus postprandial walking; WD-R, 
Western diet high-fat meal plus postprandial resting; WD-W, Western diet high-fat meal plus postprandial 
walking. 
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Heart rate, blood pressure and endothelial adhesion molecules 
Heart rate was higher after walking for both meals (P<0.001). Meal type had no effect on heart rate 
values over time. No meal effect was observed for systolic and diastolic blood pressure. However, 
lower values were observed after walking compared to resting (P<0.001). Data are summarized in 
Figure 2-6. The endothelial markers sICAM-1 and sVCAM-1 significantly decreased over time, 
with no meal or activity effect. For sE-selectin, no effect was found for time, meal, or activity 
(Table 2-8). 
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Figure 2-6 Fasting (0 h) and postprandial (1.5, 3.0, 4.5 h) blood pressure (A + B) and heart rate (C) in the 
four treatments in participants at high risk of cardiovascular disease. Mean ± SEM, n = 26. §§§P<0.001, 
§§P<0.01, §P<0.05 activity effect for specific time point. MD-R, Mediterranean-type diet meal plus 
postprandial resting; MD-W, Mediterranean-type diet meal plus postprandial walking; WD-R, Western diet 
high-fat meal plus postprandial resting; WD-W, Western diet high-fat meal plus postprandial walking.
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Table 2-8 Fasting and postprandial soluble endothelial adhesion molecules and oxidized LDL in the four treatments in participants at high risk of cardiovascular 
disease1  
 Fasting Postprandial P-values from linear mixed models 
 0 h 1.5 h 3.0 h 4.5 h time meal activity 
meal x 
activity 
meal x 
time 
activity x 
time 
Plasma sICAM-1 (ng/mL)    0.030 0.945 0.367 0.028 0.639 0.475 
WD-W 158 ± 6.77 153 ± 6.17 147 ± 5.12 151 ± 6.44       
WD-R 161 ± 8.15 157 ± 9.02 153 ± 7.35 152 ± 7.64       
MD-W 165 ± 8.78 166 ± 10.7 152 ± 7.21 152 ± 7.45       
MD-R 168 ± 9.67 152 ± 6.77 160 ± 5.89 150 ± 6.11       
Plasma sVCAM-1 (ng/mL)    <0.001 0.021 0.591 0.388 0.508 0.097 
WD-W 534 ± 29.0 509 ± 22.7 490 ± 25.0 483 ± 24.9       
WD-R 526 ± 20.6 512 ± 19.9 475 ± 21.9 481 ± 21.5       
MD-W 536 ± 26.0 528 ± 25.1 502 ± 23.7 496 ± 24.7       
MD-R 502 ± 22.5 511 ± 23.0 459 ± 21.9 467 ± 23.3       
Serum sE-selectin (ng/mL)    0.207 0.889 0.862 0.248 0.253 0.263 
WD-W 35.8 ± 2.60 34.0 ± 2.60 34.5 ± 2.61 34.7 ± 2.83       
WD-R 36.2 ± 2.89 34.6 ± 2.88 34.3 ± 2.75 34.1 ± 2.72       
MD-W 36.4 ± 3.13 34.1 ± 2.72 33.9 ± 2.79 35.3 ± 2.91       
MD-R 35.1 ± 2.61 34.1 ± 2.53 33.3 ± 2.30 34.3 ± 2.77       
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Table 2-8 continued  
 Fasting Postprandial P-values from linear mixed models 
 0 h 1.5 h 3.0 h 4.5 h time meal activity 
meal x 
activity 
meal x 
time 
activity x 
time 
Plasma oxLDL (ng/mL)    <0.001 0.068 0.473 0.415 0.820 0.323 
WD-W 81.8 ± 8.32 76.7 ± 8.92 80.5 ± 8.25 89.1 ± 11.4       
WD-R 78.7 ± 7.55 77.4 ± 8.68 88.0 ± 11.5 82.2 ± 7.80       
MD-W 83.4 ± 10.3 76.0 ± 10.8 82.1 ± 10.1 85.9 ± 10.5       
MD-R 81.4 ± 9.30 71.5 ± 6.86 81.7 ± 8.40 85.0 ± 10.4       
1Shown as mean ± SEM, n = 26. P-value for meal x time x activity interaction not significant, data not shown.  
oxLDL, oxidized Low-Density Lipoprotein; sE-Selectin, soluble endothelial-selectin; sICAM-1, soluble intercellular adhesion molecule-1; sVCAM-1, soluble 
vascular cell adhesion molecule-1; MD-R, Mediterranean-type diet meal plus postprandial resting; MD-W, Mediterranean-type diet meal plus postprandial 
walking; WD-R, Western diet high-fat meal plus postprandial resting; WD-W, Western diet high-fat meal plus postprandial walking. 
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Plasma markers of inflammation and oxidation 
Plasma IL-6 significantly increased over time, with no effect being observed for meal or activity 
(Figure 2-7). Statistical analysis of AUC-data revealed an effect for activity (P=0.035). Here, 
higher plasma IL-6 concentrations were observed after walking compared to resting (AUC in 
pg/mL x min: WD-W 72.0 ± 34.0; WD-R 14.3 ± 38.8; MD-W 70.8 ± 39.4; MD-R 5.60 ± 26.0). For 
plasma oxLDL concentrations, an effect was observed for time (P<0.001) but not for meal or 
activity (Table 2-8). 
 
 
Figure 2-7 Fasting (0 h) and postprandial (1.5, 3.0, 4.5 h) plasma IL-6 concentrations in the four treatments 
in participants at high risk of cardiovascular disease. Mean ± SEM, n = 26. §P<0.05 activity effect for 
specific time point. IL, interleukin; MD-R, Mediterranean-type diet meal plus postprandial resting; MD-W, 
Mediterranean-type diet meal plus postprandial walking; WD-R, Western diet high-fat meal plus 
postprandial resting; WD-W, Western diet high-fat meal plus postprandial walking. 
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Plasma α-tocopherol, retinol, ß-carotene, Vitamin C and TEAC 
Plasma α-tocopherol concentrations were higher after MD compared to WD (P=0.032). For plasma 
retinol concentrations, a significant effect was found for time (P=0.014) but not for meal or activity. 
Plasma ß-carotene concentrations were significantly higher after MD compared to WD (P=0.002) 
Activity had no effect on the postprandial concentration of retinol, α-tocopherol, or ß-carotene. 
Postprandial vitamin C concentrations were higher after MD compared to WD (P<0.001) and after 
walking compared to resting (P=0.002) (AUC in mg/L x min: WD-W -305 ± 59.6; WD-R -396 ± 
84.0; MD-W 113 ± 56.4; MD-R -44.5 ± 48.1). Plasma TEAC was higher after MD compared to 
WD (P=0.001). Data are summarized in Table 2-9.  
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Table 2-9 Fasting and postprandial plasma α-tocopherol, retinol, ß-carotene, and TEAC in the four treatments in participants at high risk of cardiovascular 
disease1 
 Fasting Postprandial P-values from linear mixed models 
 0 h 1.5 h 3.0 h 4.5 h time meal activity 
meal x 
activity 
meal x 
time 
activity x 
time 
Plasma α-tocopherol (µmol/L)    0.001 0.032 0.345 0.195 0.732 0.499 
WD-W 40.7 ± 1.50 38.4 ± 1.46 38.8 ± 1.77 40.3 ± 1.49       
WD-R 40.3 ± 1.45 39.7 ± 1.49 38.7 ± 1.45 40.5 ± 1.68       
MD-W 40.1 ± 1.57 39.7 ± 1.59 38.8 ± 1.57 41.1 ± 1.96       
MD-R 41.0 ± 1.68 40.9 ± 1.74 39.6 ± 1.80 41.4 ± 1.84       
Plasma retinol (µmol/L)    0.014 0.837 0.543 0.074 0.744 0.760 
WD-W 3.35 ± 0.20 3.29 ± 0.20 3.27 ± 0.21 3.35 ± 0.19       
WD-R 3.26 ± 0.19 3.31 ± 0.19 3.25 ± 0.19 3.34 ± 0.18       
MD-W 3.28 ± 0.19 3.30 ± 0.19 3.24 ± 0.18 3.38 ± 0.16       
MD-R 3.42 ± 0.19 3.43 ± 0.18 3.32 ± 0.19 3.45 ± 0.18       
Plasma ß-carotene (µmol/L)    0.291 0.002 0.571 0.224 0.725 0.267 
WD-W 0.87 ± 0.08 0.84 ± 0.07 0.85 ± 0.08 0.84 ± 0.07       
WD-R 0.82 ± 0.07 0.81 ± 0.07 0.79 ± 0.07 0.81 ± 0.07       
MD-W 0.81 ± 0.07 0.81 ± 0.07 0.80 ± 0.07 0.83 ± 0.08       
MD-R 0.85 ± 0.09 0.86 ± 0.09 0.84 ± 0.09 0.84 ± 0.09       
 
  
   
 
 
5
4
 
 
C
H
A
P
T
E
R
 2
: M
A
N
U
S
C
R
IP
T
 1
 
Table 2-9 continued 
 Fasting Postprandial P-values from linear mixed models 
 0 h 1.5 h 3.0 h 4.5 h time meal activity 
meal x 
activity 
meal x 
time 
activity x 
time 
Plasma vitamin C (µmol/L)    0.307 <0.001 0.002 0.343 0.662 0.720 
WD-W 61.4 ± 2.92 53.9 ± 2.51 52.9 ± 2.56 54.7 ± 3.05       
WD-R 61.8 ± 3.32 51.4 ± 2.09 51.0 ± 2.71 54.1 ± 2.34       
MD-W 60.7 ± 3.44 63.8 ± 3.57 63.2 ± 3.58 63.9 ± 3.15       
MD-R 61.7 ± 3.14 59.8 ± 2.84 60.9 ± 3.17 61.3 ± 2.47       
Plasma TEAC2    0.009 0.001 0.354 0.684 0.467 0.848 
WD-W 1.00 ± 0.02 0.96 ± 0.02 0.95 ± 0.02 0.95 ± 0.02       
WD-R 0.97 ± 0.02 0.96 ± 0.02 0.95 ± 0.02 0.95 ± 0.02       
MD-W 0.99 ± 0.02 0.99 ± 0.01 0.96 ± 0.01 0.97 ± 0.01       
MD-R 0.98 ± 0.02 1.00 ± 0.02 0.97 ± 0.02 0.97 ± 0.02       
1Shown as mean ± SEM, n = 26. P-value for meal x time x activity interaction not significant, data not shown. 
2Plasma TEAC in mmol of trolox equivalents/L. 
TEAC, trolox equivalent antioxidative capacity; MD-R, Mediterranean-type diet meal plus postprandial resting; MD-W, Mediterranean-type diet meal plus 
postprandial walking; WD-R, Western diet high-fat meal plus postprandial resting; WD-W, Western diet high-fat meal plus postprandial walking. 
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DISCUSSION 
The aim of the present randomized, controlled, crossover trail was to investigate the acute impact of 
dietary composition and moderate postprandial walking on metabolic, inflammatory, and oxidative 
postprandial events in adults with a CVD risk phenotype. As expected, significant alterations in 
parameters of lipid, glucose, and insulin metabolism were observed following the ingestion of both 
meal types. Previous intervention studies have shown that the ingestion of a high-fat meal induces a 
pronounced and sustained increase in serum triglycerides, and that the postprandial lipemic 
response is directly proportional to the amount of fat ingested (2, 28, 29). Available research data 
are equivocal in terms of whether the fatty acid composition of high-fat meals, in particular the SFA 
content, plays an important role in postprandial lipemia (2, 28–33). In the present study, 
postprandial triglycerides were significantly higher after WD, which may be attributable to the 
higher fat content of this meal (59.4 g vs. 40.1 g), and/or to the higher proportion of SFAs (32.0 g 
vs. 5.1 g) (Table 2-4). In contrast to previous postprandial exercise trials, activity had no effect on 
postprandial triglycerides over time. Research suggests that acute exercise in the 18 h pre-meal to 
90 min post-meal period is effective in terms of attenuating postprandial lipemia (28). However, 
studies demonstrating the attenuating effects of post-meal moderate exercise on postprandial 
lipemia involved exercise bouts of higher duration (e.g., 90 min), compared to the 30 min walking 
period used in the present study (34, 35). This shorter exercise duration may explain the absence of 
any effect for activity in the present trial. As with postprandial triglycerides, postprandial NEFAs 
were significantly higher after WD compared to MD. The postprandial decrease in NEFAs observed 
following consumption of both meal types is probably attributable to the increase in postprandial 
insulin, which suppresses intracellular lipase activity (36). The observed attenuation in postprandial 
serum NEFA suppression after walking may reflect an increase in the lipolysis of triglycerides 
stored in adipose tissue in order to supply the working muscle, since research has shown that even 
during low-intensity exercise, adipose tissue lipolysis appears to increase 2- to 5-fold above resting 
levels (37). However, comparison of AUC data revealed no activity effect for postprandial NEFAs, 
which emphasizes the statistical significance, rather than the physiological relevance, of the 
described activity effect. 
The ingestion of both test meals resulted in a postprandial increase in glucose and insulin. This was 
significantly higher after MD, due to the higher total carbohydrate content of this meal type (133 g 
vs. 93.7 g). The high insulin response after both meals caused a rapid decline in postprandial 
glucose, with lower plasma glucose concentrations being observed 4.5 h postprandially than at 
baseline. Previous research suggests that acute post-meal exercise is beneficial in terms of 
postprandial glycemic control, in particular among high risk adults (38). However, the present data 
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do not support this hypothesis, since significantly higher plasma glucose concentrations were found 
directly after walking (1.5 h postprandial) for both meal types. This may have been attributable to 
the timing of the present walking sessions, which commenced immediately after meal consumption, 
since moderate exercise in the early postprandial period (< 30 min post-meal) can lead to glucose 
elevation secondary to endogenous glucose production (39, 40). However, the AUC data revealed 
no effect for activity. A plausible hypothesis is, that the glucose-lowering effect of walking might 
have occurred in the earlier postprandial period (< 90 min postprandial), as shown in previous 
postprandial trials (41).  
For both meal types, heart rates were significantly higher after walking. However, no effect of meal 
type was found on postprandial heart rate, indicating that the high energy content of the meals, 
rather than their differing nutritional content, was responsible for the increase in postprandial heart 
rate over time (42). Increase in heart rate following the consumption of a meal is compensated for 
by a decrease in blood pressure, which is even more prominent in older adults (43). As expected, a 
significant decrease was observed in postprandial blood pressure over time. This was independent 
of meal composition but significantly higher after walking. This finding is consistent with the more 
pronounced increase in heart rate observed after walking and is of clinical importance considering 
the participants high baseline blood pressure. 
Previous postprandial studies have shown, that meals that are rich in fat and energy lead to a meal-
induced impairment of parameters of endothelial function (31, 44, 45). In this context, the quality of 
the fat, rather than simply the quantity of the fat, is important, in particular the amount of SFA (33, 
46). Surprisingly, the pronounced and sustained hyperlipidemia, hyperglycemia, and 
hyperinsulinemia induced by all four of the present treatment conditions, did not lead to increased 
endothelial activation. In fact, the endothelial-derived parameters (sVCAM-1 and sICAM-1) 
decreased over time, indicating a slight improvement in endothelial function during the 4.5 h time 
frame. These findings support data generated in a previous postprandial trial by our study group 
(47). The slight postprandial improvement in endothelial function may be attributable to diurnal 
fluctuations, since vascular function exhibits circadian variability, with an attenuation during the 
early morning (48–50). 
Several postprandial studies have demonstrated an increase in postprandial IL-6 following the 
ingestion of high-fat, high energy meals (28, 51–53). This is consistent with the present data, which 
showed a significant increase in postprandial IL-6 over time following both meal types. 
Furthermore, comparison of the AUC data revealed higher postprandial IL-6 concentrations after 
walking. During exercise, IL-6 is secreted from skeletal muscle tissue in an exponential manner in 
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response to exercise (54), and is therefore referred to as a myokine. Myokines are generally 
considered to be anti-inflammatory cytokines (28, 55–57). However, the release of IL-6 from 
muscle mass is dependent, inter alia, on the intensity and the duration of the exercise, as well as the 
amount of muscle mass involved (56, 57). Since the present walking session was of low duration 
and moderate intensity, it is questionable whether the stimulus was sufficient to trigger a 
pronounced systemic IL-6 response, or if the higher postprandial IL-6 concentration observed after 
walking was due instead to other physiological factors (e.g., systemic stress response).  
In the present study, postprandial oxLDL declined at the beginning of the postprandial period, 
followed by an increase that resulted in higher concentrations at 4.5 h compared to baseline. The 
increase in plasma oxLDL in the later postprandial period indicates that the consumption of a single 
high energy meal might be sufficient to trigger postprandial oxidative stress. Surprisingly, meal 
composition (e.g., higher amount of antioxidants in MD) had no influence in the present trial. In 
general, the effect of meal ingestion on postprandial oxLDL is a contentious issue (58–60). In 
contrast to our expectations, walking had no effect on postprandial oxLDL concentrations, despite 
the fact that acute aerobic exercise appears to increase oxLDL concentrations in high CVD risk 
adults (61). This may suggest that the stimulus of the present walking session was insufficient to 
cause a significant impact on postprandial oxLDL.  
The observed decrease in TEAC over the postprandial period is inconsistent with the hypothesis 
that high-fat challenges increase postprandial oxidative stress (45). However, since the observed 
decrease was minimal, the physiological relevance of this finding is questionable (Table 2-9). The 
postprandial plasma concentrations of α-tocopherol, ß-carotene, and vitamin C were higher after 
MD, which is consistent with the higher nutrient content of this test meal (Table 2-9). The higher 
concentration of postprandial vitamin C observed after walking may have been attributable to the 
higher concentration of postprandial glucose detected after walking. Since vitamin C and glucose 
share a common transport system, acute hyperglycemia may induce the transport of vitamin C from 
cells, thus triggering the depletion of intracellular vitamin C (62).  
The major strengths of the present study were the controlled, crossover design, the absence of study 
dropouts, and the high rate of treatment compliance. In addition to the strictly controlled 
postprandial protocol, a wide range of postprandial parameters were examined and statistically 
significant time- and treatment effects were observed. In contrast to previous studies of exercise and 
postprandial metabolism, the analysis focused on meals reflecting typical dietary patterns and not 
on the administration of nutrient solutions (e.g., fat tolerance tests). The 30 min postprandial session 
of moderate walking was designed to be both suitable for daily life and easy to implement. The 
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postprandial walking session was designed to be a conventional walk outdoors, in order to generate 
realistic conditions (transferable to everyday situations) and a high relevance for public health. The 
walking sessions were conducted under stable weather conditions (June and July 2017) in the 
morning hours, standardized for each participant. Furthermore, walking speed of the participants 
was measured and standardized between the sessions. The metabolic responses (plasma lactate 
concentrations) of participants showed no significant differences between WD-W and MD-W, 
which is a relevant indicator for good standardization as well (Table 2-7). However, despite the 
good standardization of the walking sessions, it cannot be ruled out, that the lack of environmental 
control between resting and walking might have been a potential confounding factor.  
A potential limitation of the study was the time intervals used for the measurement of endpoints. 
Particularly in terms of parameters of glucose metabolism, it would have been relevant to include 
postprandial time points at 30 min and 1 h, in order to evaluate possible walking effects on the early 
postprandial rise in plasma glucose and serum insulin. However, due to scheduling reasons, no 
further time points could be included in the study design. Furthermore, the duration of the 
postprandial measurements (4.5 h) in the present study may not have been long enough to represent 
the extent and duration of the entire postprandial period. However, the fact that the majority of the 
outcome measures were about to reach baseline values at 4.5 h postprandially indicates otherwise. 
In conclusion, in older adults with a CVD risk phenotype the MD, which is rich in unsaturated fatty 
acids, dietary fiber, vitamins, and minerals, was associated with superior effects on several 
postprandial parameters (e.g., triglycerides, antioxidants) in comparison to the WD. The present 
data revealed no relevant difference between postprandial walking and resting. However, 
postprandial walking had no obvious negative effects in this population either. On the basis of the 
present data, in older adults with a CVD risk phenotype none of our four treatments (WD-W, WD-
R, MD-W, MD-R) can be rated as superior regarding their acute effects on the measured 
postprandial metabolic, oxidative, and inflammatory parameters. 
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ABSTRACT  
Research suggests that attention, mood, and satiety can be influenced by meal composition and 
postprandial activity. The present study examined whether this hypothesis applies to persons with a 
risk phenotype for cardiovascular/neurodegenerative diseases. A randomized crossover trial was 
conducted in subjects with metabolic syndrome traits (n = 26, 8 female, age 70±5, BMI 30.3 ± 2.3 
kg/m2). Each subject participated in four interventions: isoenergetic (4300 kJ) meals (Western diet 
high-fat, WD, and Mediterranean-type diet, MD) followed by either 30 min of moderate walking 
(4.6 ± 0.1 km/h) or rest. Attention, mood, satiety and plasma cortisol concentrations were measured 
at fasting and 1.5, 3.0, 4.5 h postprandially. Data were analyzed by linear mixed models. In all 
interventions, attention increased continuously in the postprandial period (time effect, P<0.001). 
After WD, attention was lower after walking compared to resting (meal x activity effect, P<0.05). 
Postprandial mood was generally “good” with no intervention effects. Postprandial satiety increased 
reaching maximum at 1.5 h after meal (time effect, P<0.001) and was higher after MD compared to 
WD (meal effect, P<0.001). In all interventions, plasma cortisol decreased similar to its diurnal 
variation (time effect, P<0.001). In our subjects, meal composition had no relevant impact on 
attention and mood. After typical WD, resting instead of walking seems to have a more beneficial 
effect on postprandial attention. MD leads to a strong and long-lasting feeling of satiety, possibly 
resulting in reduced energy intake in the further course of the day and, thus, long-term effect on 
weight control. 
 
This trial was registered at http://www.germanctr.de and http://drks.de under identifier 
DRKS00012409.  
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INTRODUCTION 
Research suggests that the sedentary lifestyle of today’s Western societies is associated with the 
development of chronic systemic low-grade inflammation, which is at the root of many typically 
Western diseases associated with the metabolic syndrome [1]. Due to the anti-inflammatory 
capacities of aerobic physical activity, integration of regular activity sessions into everyday life 
seems to be beneficial regarding improvement of general health and, furthermore, regarding 
protection of the brain from metabolic stress [1,2]. In addition, especially regular aerobic activity 
has been consistently reported to prevent mental illness (e.g., depression) and alleviate mood 
problems, as well as to improve cognitive and brain function, but even acute, moderate activity 
sessions seem to exert similar effects [2–5]. In this context, different research studies describe 
modulators of effect size being the temporal sequencing of cognitive assessment in relation to 
exercise (e.g., following exercise session or during exercise session), the modality of aerobic 
training (e.g., cycling or running), and the cognitive parameters measured (e.g., memory or 
processing speed), as well as age and medical condition [3,4,6]. 
While supplementation studies suggest that single nutrients (e.g., docosahexaenoic acid) can 
increase cognitive performance, research on the effects of whole meals and, especially, different 
meal compositions on cognitive function and mood is limited [7]. Compared to a meal intake which 
is in accordance with the Western dietary pattern, a Mediterranean diet provides higher levels of 
nutrients including essential fatty acids, vitamins, minerals, and antioxidants, which seem to support 
brain function. Additionally, the Mediterranean dietary pattern contains fewer refined carbohydrates 
and saturated fatty acids, which have been associated with cognitive deficits [7,8]. Therefore, it is 
likely that a regular choice of food items characteristic for the Mediterranean dietary pattern is 
beneficial with regard to the prevention of age-related cognitive deficits [9,10]. In this context, 
numerous epidemiological studies suggest that an adherence to plant-based dietary patterns, 
especially the Mediterranean dietary pattern, is associated with improved cognitive performance, 
slower age-related cognitive decline and lower risk of cognitive impairment and neurodegenerative 
disease in older adults [11–14]. 
Current randomized interventions trials evaluating the acute interactive effects of meal composition 
and physical activity on cognitive performance and emotions are limited [15,16] and to the best of 
our knowledge, no previous human study has investigated the acute effects of postprandial exercise 
suitable for daily implementation neither on postprandial attention as a complex cognitive function, 
nor on mood/emotions following the consumption of meals reflecting different dietary patterns, 
especially in subjects with a risk phenotype for the development of cardiovascular and 
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neurodegenerative diseases (e.g., elevated age; characteristics of metabolic syndrome). Since 
current research suggests that breakfast as the first meal of the day is most important from a dietary 
perspective [17] and is vital for optimal cognitive function and intellectual performance by 
providing readily available energy to the brain [18], the test meals in the present study were 
provided as breakfast challenges after an overnight fast (≥ 12 h). The study tested two main 
hypotheses: (i) a Mediterranean-type diet meal (MD) generates higher postprandial satiety, 
postprandial attention and a better subjective mood than an iso-energetic Western diet high-fat meal 
(WD); and (ii) Moderate walking in the postprandial period as compared to remaining sedentary, 
results in increased postprandial attention and a better subjective mood. In addition to these main 
hypotheses, this study examined the impact of plasma cortisol concentration on postprandial 
attention, since elevated systemic cortisol concentrations have been associated with detrimental 
effects on cognition and a long-term contribution to Alzheimer’s disease pathology [19,20]. In this 
context, the present study evaluated if the activity session or the intake of high-energy meals were 
high enough stressors to trigger cortisol release and if effects of different plasma cortisol 
concentrations on postprandial attention are relevant even in an acute study design. The data 
presented in this manuscript are ancillary examinations (secondary outcome measures) of the 
intervention study which has initially been designed to investigate the effects of meal composition 
and postmeal walking on different metabolic, inflammatory, oxidative, and endothelial events in the 
postprandial period, with postprandial triglycerides as primary outcome measure [21]. 
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MATERIALS AND METHODS 
Participants 
Details of the study design and subject recruitment, enrollment, and randomization have been 
described previously [21]. In brief, interested volunteers (n = 31) aged 60 to 80 y attended a 
screening that included physical assessments (e.g., body height and weight, waist circumference), 
clinical assessments (e.g., liver and kidney function, serum lipids and lipoproteins, plasma glucose), 
medical history, and the documentation of dietary habits. Main inclusion criteria were: (i) 
overweight or obesity stage 1 (BMI 27–34.9 kg/m2), (ii) visceral fat distribution (waist 
circumference ≥ 94 cm for men and ≥ 80 cm for women), and (iii) prehypertension (systolic blood 
pressure: ≥ 120 mmHg, and ≤ 139 mmHg; diastolic blood pressure: ≥ 80 mmHg, and ≤ 89 mmHg) 
or stage 1 hypertension (systolic blood pressure: ≥ 140 mmHg, and ≤ 159 mmHg; diastolic blood 
pressure: ≥ 90 mmHg, and ≤ 99 mmHg). In addition, study eligibility required fulfillment of at least 
one of the following criteria: (i) dyslipidemia (fasting serum triglycerides ≥ 1.7 mmol/L and/or 
serum HDL-cholesterol < 1.0 mmol/L for men and < 1.3 mmol/L for women), (ii) fasting plasma 
glucose ≥ 5.6 mmol/L) or iii) a pro-inflammatory state (hs-CRP ≥ 2.0 mg/L). A total of 26 subjects 
(18 male, eight female) were included in the study. All subjects completed the entire intervention 
trial, and their respective data were included in the analysis. The study was conducted in accordance 
with the guidelines laid down in the 1964 Declaration of Helsinki and its later amendments. All 
study procedures were approved by the ethics committee of the Medical Faculty of the University 
of Bonn, Germany (ethic approval code 070/17). Written informed consent was obtained from all 
subjects prior to inclusion. This trial was registered at http://www.germanctr.de and http://drks.de 
under identifier DRKS00012409. 
Study design 
This postprandial study was conducted as a randomized controlled crossover trial at the Department 
of Nutrition and Food Sciences, Nutritional Physiology (University of Bonn, 53115 Bonn, 
Germany). All subjects participated in four treatment conditions, each lasting 4.5 h from morning to 
afternoon. Study days were separated by 2 wk wash-out periods. The order of treatments was 
randomized for each subject via computer-generated randomization tables (Microsoft Excel 2010, 
Microsoft Corp., Redmond, WA., USA). The four treatment conditions were as follows: (i) MD 
plus 30 min postprandial walking; (ii) MD plus 30 min postprandial resting; (iii) WD plus 30 min 
postprandial walking and (iv) WD plus 30 min postprandial resting. On each treatment day, venous 
blood sampling for cortisol analysis and questionnaires for attention, mood, and satiety were taken 
at fasting (0 h) and at three time points during the postprandial period (1.5, 3.0, and 4.5 h). The 
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outcome measures shown in the present manuscript were examined as secondary outcome measures 
in the context of the randomized crossover trial evaluating the impact of meal composition and 
postmeal walking on selected postprandial events. Further details of this trial and the study design 
have been previously described [21]. 
Test meals 
WD and MD test meals (challenges) were designed specifically for the purposes of the present 
study. The meals were iso-energetic (4300 kJ/meal) and iso-nitrogenous. WD was rich in total fat, 
saturated fatty acids, and animal protein. MD was rich in unsaturated fatty acids, dietary fiber, and 
antioxidative compounds (Table 3-1). The main components of the WD were croissant, bread roll, 
jam, butter, cold cuts, boiled egg and cream yogurt. The MD mainly comprised ciabatta, smoked 
salmon, muesli, fruit, and vegetables. Details of food items and nutrient composition of MD and 
WD have been previously described [21]. Study personnel prepared both breakfast challenges 
according to a standardized protocol, which included the weighing of each food item to the nearest 
gram. The test meals were consumed in the morning as first meal of the day and had to be ingested 
within 20 min. 
Table 3-1 Nutrient composition per serving of the two test meals (adapted from [21]). 
Energy and Nutrients WD MD 
Energy (kJ) 4247 4251 
Protein (g) 26.1 25.9 
Carbohydrates (g) 93.7 133 
Dietary fiber (g) 4.2 14.5 
Total fat (g) 59.4 40.1 
SFAs (g) 32.0 5.1 
MUFAs + PUFAs (g) 23.8 30.9 
ß-carotene (mg) 0.2 5.4 
Vitamin E1 (mg) 2.3 12.1 
Vitamin C (mg) 9 102 
1-Tocopherol equivalent. MD, Mediterranean-type diet meal; MUFAs, monounsaturated fatty acids; 
PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids; WD, Western diet high-fat meal. 
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Physical activity 
The activity (walking or resting) was conducted directly after meal intake. The 30 min walking 
session was performed outdoors on the University of Bonn campus. Participants were accompanied 
by study personnel. The duration was selected to reflect current recommendations for the minimum 
level of moderate-intensity physical activity required on most days of the week to reduce the risk of 
cardiovascular events [22]. During the first walking session, the subjects were told to walk at a 
moderate pace, reflecting their individual speed of comfort. For standardization purposes, this speed 
was then reproduced during the following walking session. The resting (control) phase was 
conducted at the study location. Each participant remained in a supine position, and was told to 
abstain from any distraction over a period of 30 min [21]. 
Measurements 
Assessment of cognitive abilities: attention/focus 
The German version of the Frankfurt Attention Inventory 2 (FAIR-2, Test version A) was used, 
which is a validated paper and pencil measure of visual selective attention as one facet of cognitive 
function with good psychometric properties [23,24] and proven sensitivity to pharmacological 
interventions [25–27]. Test completion requires the accurate and quick identification and marking 
of target items among similar non-target items. In this context, a continuous line needs to be drawn 
under each row of items, with a peak clearly pointing into the target-items. Participants need to be 
alert and show a rapid reaction time, as well as the ability to maintain focused attention throughout 
the test duration. Both accuracy and speed are taken into account when evaluating test performance 
and are combined into an overall performance score (K score). The FAIR-2 was conducted in the 
fasting state (baseline) and 1.5, 3.0, and 4.5 h postprandially on each of the four study days. All 
subjects were familiarized with FAIR-2 prior to the commencement of the study to reduce practice 
effects. 
Assessment of subjective mood 
The German version of the Multidimensional Mood State Questionnaire (MDMQ) was used to 
assess subjective mood [28]. The MDMQ is a paper and pencil test, which uses selected adjectives 
(24 in the long form and 12 in the short form), which can be assigned to three bipolar dimensions of 
mood: (i) good mood vs. bad mood, (ii) alertness vs. fatigue, and (iii) ease vs. unease. For each 
adjective, subjects were asked to classify their current feeling on a five-point scale from 1 (“not at 
all”) to 5 (“very much”). An overall score was calculated for each of the three bipolar dimensions, 
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with higher (or lower) values associated with the respective positive (or negative) sensations. The 
test was conducted in the fasting state (baseline) and 1.5, 3.0, and 4.5 h postprandially on each of 
the four study days. The two versions of the short form (type A and B) were used alternately at the 
respective time points, with the order being randomized for each subject. All subjects were 
familiarized with the MDMQ prior to the commencement of the study to reduce practice effects. 
Assessment of hunger, appetite, and satiety 
The sensations ‘hunger’, ‘appetite’ and ‘satiety’ were assessed using 100-mm visual analogue 
scales (VAS). On three different VAS, the sensations ‘hunger’, ‘appetite’ and ‘satiety’ were paired 
with the correspondingly opposite sensations ‘no hunger’, ‘no appetite’ and ‘no satiety’. Subjects 
were requested to make a vertical mark on each scale that best matched their current feeling. Each 
score was determined by measuring the distance from the left side of the line to the vertical mark. 
Since VAS values for hunger and appetite were highly correlated (r = 0.8), both were combined to a 
value describing the overall sensation of hunger / desire to eat (arithmetic mean). The test was 
conducted in the fasting state (baseline) and 1.5, 3.0, and 4.5 h postprandially on each of the four 
study days. All subjects were familiarized with the VAS scales prior to the commencement of the 
study to reduce practice effects. 
Blood sample processing and analysis 
Details of the pre-analytical procedures of fasting and postprandial blood samples have been 
described previously [21]. Fasting and postprandial cortisol was analyzed in duplicate using 
commercially available enzyme-linked immunoassay kits (IBL International GmbH, Hamburg, 
Germany) in accordance with the manufacturer’s instructions and recommended quality control 
procedures. 
Sample size calculation 
The outcomes measured in the present manuscript were examined as secondary outcome measures 
as part of the randomized crossover trial evaluating the impact of meal composition and postmeal 
walking on selected postprandial events. Therefore, a priori sample size calculation was based on 
serum triglycerides as primary outcome measure of the entire postprandial intervention study [21]. 
Statistical analysis 
All statistical analyses were performed using the IBM SPSS statistical software package (SPSS 
version 25, IBM Corporation, Somers, NY, USA). The linear mixed model procedure was used to 
test the effects of meal and activity, time points, and their interaction on postprandial cortisol and 
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FAIR-2, MDMQ, and VAS values. Meal type (WD, MD); activity (walking, resting); time points 
(1.5, 3.0, 4.5 h postprandially); and interactions (meal x activity, meal x time, activity x time, and 
meal x activity x time) were set as fixed factors and subject identifier as a random factor. Baseline 
values were included as covariates. For FAIR-2 analysis, the order of study visits was set as an 
additional covariate in order to control for any residual practice effects. In all tests, the residuals 
showed no relevant deviations from a normal distribution. In case of significant meal x activity 
interaction, the linear mixed model procedure was performed separately for WD and MD to 
examine possible activity effects for both meal types. Furthermore, incremental area under the 
curve (iAUC) was calculated for all parameters using the trapezoidal rule, and the linear mixed 
model procedure was performed to test for meal, activity, and meal x activity effects. In all 
analyses, significance level was set at P < 0.05. Descriptive data are presented as arithmetic mean x 
standard error of the mean (SEM), unless otherwise stated.  
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RESULTS 
Participants 
Baseline characteristics are shown in Table 3-2. All participants were overweight (46.2%) or obese 
(53.8%), had a visceral fat distribution, and were prehypertensive or displayed stage 1 hypertension 
[21]. 
Table 3-2 Baseline characteristics of participants (adapted from [21]).1 
Parameters Total 
(n = 26) 
Age (y) 69.9 ± 4.7 
BMI (kg/m2) 30.3 ± 2.3 
Body fat (%) 38.4 ± 8.1 
Waist circumference (cm) 104 ± 5.8 
Systolic blood pressure (mmHg) 149 ± 16.4 
Diastolic blood pressure (mmHg) 88.3 ± 7.3 
Serum triglycerides (mmol/L) 1.76 ± 0.79 
Serum total cholesterol (mmol/L) 4.86 ± 1.60 
Serum HDL cholesterol (mmol/L) 1.61 ± 0.37 
Serum LDL cholesterol (mmol/L) 3.19 ± 0.76 
Plasma glucose (mmol/L) 5.64 ± 0.66 
Serum hs-CRP (mg/L) 2.5 ± 3.0 
Age (y) 69.9 ± 4.7 
BMI (kg/m2) 30.3 ± 2.3 
Body fat (%) 38.4 ± 8.1 
Waist circumference (cm) 104 ± 5.8 
Systolic blood pressure (mmHg) 149 ± 16.4 
1Shown as mean ± SD, n = 26. hs-CRP, high sensitivity C-reactive protein. 
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FAIR-2 
In all four treatment conditions, the overall test performance (K score) increased over time 
(P<0.001) which was due to an increase in speed (P<0.001) rather than an increase in accuracy 
(P=0.429) over time. A significant interaction for meal x activity (P=0.026) was observed: for WD 
but not MD, K scores were lower after walking compared to resting (P<0.001) (Figure 3-1a, Table 
3-3). Comparison of iAUC data revealed an effect of meal type (P=0.045) and activity (P=0.027), 
with higher K scores for MD compared to WD and for resting compared to walking (Figure 3-1b). 
 
Figure 3-1 Fasting and postprandial attention (FAIR-2, K score) according to treatment condition: (a) K 
score over time: the overall test performance increased over time (P<0.001). A significant interaction 
for meal x activity (P=0.026) was observed: for WD but not MD, values were lower after walking 
compared to resting (P<0.001) (b) iAUC of K score: data revealed an effect of meal type (P=0.045) and 
activity (P=0.027). FAIR-2, Frankfurt Attention Inventory 2; iAUC, incremental area under the curve; 
MD, Mediterranean-type diet meal; WD, Western diet high-fat meal. 
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Table 3-3 Fasting and postprandial attention (FAIR-2, K score)1,2 
 
Fasting Postprandial P-values from linear mixed models 
 0 h 1.5 h 3.0 h 4.5 h time meal activity 
meal x 
activity 
meal x 
time 
activity x 
time 
K score (FAIR-2)    <0.001 0.039 0.001 0.026 0.905 0.770 
WD + walking 380 ± 23.8 405 ± 24.3 420 ± 23.9 426 ± 21.8       
WD + resting 362 ± 24.9 415 ± 25.0 428 ± 21.7 426 ± 20.8       
MD + walking 352 ± 25.0 404 ± 25.4 416 ± 22.8 416 ± 21.0       
MD + resting 345 ± 22.3 399 ± 21.4 418 ± 19.4 414 ± 20.1       
1shown as mean ± SEM. P-value for meal x time x activity interaction not significant. 
2K score describes overall test performance during FAIR-2. Scores range from 0 – 640. 
FAIR-2, Frankfurt Attention Inventory 2; MD, Mediterranean-type diet meal; WD, Western diet high-fat meal. 
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MDMQ 
For the values of the dimension good vs. bad mood, a time effect was observed (P=0.014), as well 
as a significant interaction for meal x activity (P=0.027). Here, an activity effect was observed for 
MD (P=0.004) but not for WD. The values for the dimension alertness vs. fatigue were significantly 
influenced by time (P=0.006) and meal (P=0.003), with lower values after WD compared to MD. 
The values for the dimension ease vs. unease were affected by activity (P=0.022) but neither by 
time nor by meal type. For all three dimensions, neither a meal x time nor an activity x time effect 
has been observed. Comparison of iAUC data revealed no effect for meal or activity either. Data are 
summarized in Table 3-4. 
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Table 3-4 Fasting and postprandial parameters of MDMQ1,2. 
 Fasting Postprandial P-values from linear mixed models 
 0 h 1.5 h 3.0 h 4.5 h time meal activity 
meal x 
activity 
meal x 
time 
activity x 
time 
Good vs. bad mood    0.014 0.047 0.171 0.027 0.580 0.804 
WD + walking 17.4 ± 0.63 18.5 ± 0.41 18.0 ± 0.45 18.4 ± 0.35       
WD + resting 18.6 ± 0.37 18.7 ± 0.32 18.2 ± 0.35 18.2 ± 0.38       
MD + walking 17.9 ± 0.48 18.0 ± 0.36 17.7 ± 0.45 17.8 ± 0.34       
MD + resting 17.7 ± 0.54 18.1 ± 0.36 18.0 ± 0.40 18.6 ± 0.35       
Alertness vs. fatigue    0.006 0.003 0.089 0.404 0.600 0.573 
WD + walking 15.2 ± 0.79 16.4 ± 0.68 15.2 ± 0.65 14.8 ± 0.65       
WD + resting 16.7 ± 0.57 16.3 ± 0.51 16.2 ± 0.56 15.5 ± 0.67       
MD + walking 15.2 ± 0.85 14.9 ± 0.60 14.6 ± 0.71 14.2 ± 0.77       
MD + resting 15.4 ± 0.85 15.8 ± 0.60 14.4 ± 0.75 15.4 ± 0.63       
Ease vs. unease    0.444 0.107 0.022 0.248 0.253 0.837 
WD + walking 17.3 ± 0.68 17.6 ± 0.53 17.8 ± 0.53 18.1 ± 0.41       
WD + resting 18.1 ± 0.49 18.4 ± 0.39 18.2 ± 0.45 18.0 ± 0.41       
MD + walking 17.2 ± 0.51 17.8 ± 0.45 17.1 ± 0.61 17.2 ± 0.51       
MD + resting 17.5 ± 0.57 18.0 ± 0.44 17.8 ± 0.49 18.0 ± 0.51       
1shown as mean ± SEM. P-value for meal x time x activity interaction not significant.  
2values range from 5 (lower end of the scale) until 20 (upper end of the scale). 
MD, Mediterranean-type diet meal; MDMQ, Multidimensional Mood Sate Questionnaire; WD, Western diet high-fat meal. 
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VAS 
The overall sensation of hunger (desire to eat) decreased over time (P<0.001), with no meal or 
activity effect (Figure 3-2a, Table 3-5). Comparison of iAUC data confirmed these results  
(Figure 3-2b). Satiety values increased over time (P<0.001) with higher values for MD compared 
to WD (P<0.001) (Figure 3-3a, Table 3-5). This meal effect was confirmed by the iAUC data 
(Figure 3-3b). 
 
 
Figure 3-2 Fasting and postprandial hunger (desire to eat) according to treatment condition: (a) the 
overall sensation of hunger decreased over time (P<0.001) in all four treatment conditions. (b) 
iAUC revealed no meal or activity effect. iAUC, incremental area under the curve; MD, 
Mediterranean-type diet meal; VAS, visual analogue scale; WD, Western diet high-fat meal. 
 
Figure 3-3 Fasting and postprandial satiety according to treatment condition: (a) satiety increased 
over time (P<0.001) with higher values for MD compared to WD (P<0.001). (b) iAUC data 
confirmed the observed meal effect (P=0.004). iAUC, incremental area under the curve; MD, 
Mediterranean-type diet meal; VAS, visual analogue scale; WD, Western diet high-fat meal. 
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Table 3-5 Fasting and postprandial hunger and satiety1,2. 
 
Fasting Postprandial P-values from linear mixed models 
 0 h 1.5 h 3.0 h 4.5 h time meal activity 
meal x 
activity 
meal x 
time 
activity x 
time 
Desire to eat (hunger)    <0.001 0.283 0.359 0.552 0.656 0.105 
WD + walking 6.26 ± 0.67 0.85 ± 0.28 1.13 ± 0.32 2.66 ± 0.67       
WD + resting 6.38 ± 0.64 0.45 ± 0.15 1.71 ± 0.38 2.88 ± 0.65       
MD + walking 5.88 ± 0.70 0.74 ± 0.29 1.08 ± 0.34 1.85 ± 0.51       
MD + resting 6.12 ± 0.62 0.55 ± 0.23 1.15 ± 0.33 2.88 ± 0.70       
Satiety    <0.001 <0.001 0.158 0.490 0.160 0.972 
WD + walking 0.96 ± 0.30 3.35 ± 0.68 2.00 ± 0.51 1.15 ± 0.32       
WD + resting 1.04 ± 0.28 3.90 ± 0.74 2.37 ± 0.60 2.13 ± 0.53       
MD + walking 0.62 ± 0.20 4.62 ± 0.75 3.65 ± 0.70 1.88 ± 0.52       
MD + resting 0.98 ± 0.34 4.96 ± 0.81 4.02 ± 0.70 1.98 ± 0.49       
1shown as mean ± SEM. P-value for meal x time x activity interaction not significant. 
2values were measured via VAS and range from 0 (lower end of the scale) until 10 (upper end of the scale). 
MD, Mediterranean-type diet meal; VAS, visual analogue scale; WD, Western diet high-fat meal. 
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Plasma cortisol 
Postprandial cortisol concentration decreased over time (P<0.001), with no effect being observed 
for meal or activity (Figure 3-4a, Table 3-6). Comparison of AUC data confirmed these results. 
Data are summarized in Figure 3-4b. 
 
Figure 3-4 Fasting and postprandial plasma cortisol according to treatment condition: (a) 
postprandial cortisol concentration decreased over time (P<0.001) in all four treatment conditions. 
(b) iAUC data revealed no effect of meal or activity. iAUC, incremental area under the curve; MD, 
Mediterranean-type diet meal; WD, Western diet high-fat meal. 
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Table 3-6 Fasting and postprandial plasma cortisol concentration1 
 
Fasting Postprandial P-values from linear mixed models 
 0 h 1.5 h 3.0 h 4.5 h time meal activity 
meal x 
activity 
meal x 
time 
activity x 
time 
Plasma cortisol (ng/mL)    <0.001 0.810 0.160 0.863 0.659 0.569 
WD + walking 136 ± 6.46 114 ± 6.76 93.7 ± 7.86 86.6 ± 6.90       
WD + resting 133 ± 7.76 114 ± 6.07 89.6 ± 4.52 81.0 ± 4.10       
MD + walking 137 ± 7.38 114 ± 7.47 91.9 ± 4.90 89.4 ± 5.71       
MD + resting 134 ± 9.34 117 ± 5.90 88.1 ± 4.96 81.4 ± 5.55       
1shown as mean ± SEM. P-value for meal x time x activity interaction not significant, data not shown. 
MD, Mediterranean-type diet meal; WD, Western diet high-fat meal. 
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DISCUSSION 
The purpose of this study was to investigate the acute impact of dietary composition and moderate 
postmeal walking on postprandial attention (representing one aspect of cognitive function), mood, 
and the sensations of hunger and satiety in older subjects with a risk phenotype for the development 
of cardiovascular and neurodegenerative diseases. 
Prior research suggests that the consumption of breakfast is vital for optimal cognitive performance, 
since it provides readily available energy as first meal of the day after an overnight fast [15,18]. In 
the present study, the consumption of both test meals (breakfast challenges) yielded a reliable and 
substantial (10–20%) increase of postprandial attention over time. iAUC data revealed that the 
increase in postprandial attention was significantly higher after MD than after WD, which is in 
accordance with our hypothesis that a MD results in higher postprandial attention than a WD. 
Considering the fact that glucose is the main fuel for brain function and therefore plays an important 
role in general cognitive performance [29,30], the observed meal effect on postprandial attention in 
the present study might be due to the higher amount of carbohydrate in MD (133.3 g vs. 93.7 g). It 
remains unclear, whether the different nutrient composition of the breakfast challenges (Table 3-1) 
contributed to the observed results. Since an adherence to the Mediterranean dietary pattern is in the 
long run associated with improved cognitive performance and mental health, future intervention 
studies in this field of research might consider taking into account the habitual diet/nutritional status 
of their participants as a further possible influencing factor of acute nutritional effects on cognitive 
parameters such as postprandial attention. 
Furthermore, an activity effect was observed after WD, with lower postprandial attention after 
walking than after resting. From the perspective of energy availability to the brain, these findings 
are rather unexpected, since we observed higher plasma glucose concentrations after walking than 
after resting for both meal types [21]. 
An increase in postprandial cortisol concentrations could further explain the decreased attention 
values observed after the WD+walking treatment, since elevated plasma cortisol is associated with 
altered cognitive function [31]. However, our data showed no activity effect on postprandial plasma 
cortisol over time for none of the four treatments. Since the walking session in the present study 
was of moderate intensity and short duration only, the stressor might not have been high enough to 
trigger an increase in plasma cortisol concentrations [32]. However, it is possible that an activity 
effect on postprandial cortisol would have been detectable if blood samples had been taken during 
and/or directly at the end of the walking session [32]. In accordance with previous postprandial 
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trials [33,34], in the present study, postprandial cortisol significantly decreased from morning to 
afternoon, similar to its diurnal variation, and the stimulus of meal intake was not strong enough to 
alter this distinct pattern (Figure 3-4a, Table 3-6). Since postprandial attention as well as cortisol 
showed a strong time effect, it is diffcult to separate between the extent to which time influenced 
postprandial attention and the extent to which postprandial cortisol had an influence on this 
parameter. 
The fact that the increase of overall postprandial attention was due to an increase in test speed and 
not in test accuracy suggests, that the repetition of the same test procedure on each time point on 
each of the four study days led to a learning effect. This learning effect, however, cannot be 
quantified but should be taken in to account when evaluating the practical relevance of the 
statistical results. 
In contrast to a previous postprandial exercise trial conducted in healthy, habitually active, middle-
aged women, which showed an association between the consumption of breakfast and lower fatigue 
and higher overall mood and alertness post-exercise [16], in the present study, no relevant effect of 
meal intake or postprandial activity behavior on the measured mood dimensions (good vs. bad 
mood, alertness vs. fatigue, and ease vs. unease) could be observed (Table 3-4). Despite statistical 
significance, for all three dimensions, changes in mean values between all time points were minor. 
The obtained results showed that the subjects were alert, at ease and in rather good mood during the 
course of each study day (Table 3-4). Since meal or activity effects on subjective parameters like 
mood are complex to measure, it is possible that the MDMQ was not sensitive enough to determine 
clinically relevant treatment effects on mood over time [35]. 
In comparison to the present study, future intervention studies in this field of research might 
consider the habitual activity level/physical activity status of their participants as a modulator of 
effect size. It can be assumed that the intensity of an acute physical activity session is perceived 
differently depending on the activity status of a person (low or high metabolic stressor), possibly 
resulting in different effects on postprandial attention and/or postprandial emotional state. 
Research suggests that the consumption of food in the early morning leads to control and 
moderation of total energy intake throughout the whole day, since the complex carbohydrates 
usually consumed during breakfast affect activity as well as release of hormones (e.g., gastric 
inhibitory peptide, glucagon-like peptide-1, cholecystokinin), which differently affect postprandial 
plasma glucose and, consequently, satiety [18]. In the present study, the higher satiety values over 
time that were observed after MD treatments compared to WD treatments are mainly due to the 
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higher volume of the MD (781 g/MD meal vs. 390 g/WD meal), as well as the higher dietary fiber 
content (14.5 g/MD meal vs. 4.2 g/WD meal). It is possible that this marked satiating power led to 
control and moderation of total energy intake throughout the remaining day. 
The major strengths of the present study are the controlled, crossover design, the absence of study 
dropouts, and the high rate of treatment compliance. In contrast to previous studies in this flied of 
research, this trial followed a holistic approach and focused on regular meals reflecting different 
dietary patterns and not on the administration of nutrient solutions (e.g., fat tolerance tests). The 30 
min session of moderate postmeal walking was designed to be easily incorporable into daily 
routines, even by inactive or physically more restricted individuals. One limitation of the present 
work is that it is an explorative analysis of secondary outcome measures. The study was originally 
designed to investigate the effects of meal composition and postmeal walking on different 
metabolic, inflammatory, oxidative, and endothelial outcome measures in the postprandial period 
and a priori sample size calculation was based on serum triglycerides as primary outcome measure 
of the postprandial intervention study [21]. Another potential limitation of the study is the time 
points selected for the measurement of outcome measures, which may not have been representative 
of the overall postprandial period. However, for scheduling reasons, further time points and shorter 
intervals were precluded from the study design. Furthermore, the repeated use of the FAIR-2 type A 
to examine attention behavior may have led to a learning effect which might have influenced time- 
and treatment effects. However, alternate use of both test types (A and B) could not be performed as 
there was a risk of possible bias due to changes in target items and test procedures. Future 
intervention trials focusing on the evaluation of selective attention as a primary outcome measure 
might consider including a variety of test procedures focusing on different aspects of cognitive 
performance (including vigilance) and a chronometric approach might be reasonable in order to 
evaluate cognitive function more specifically. This might be especially relevant in chronic rather 
than acute intervention trials. 
CONCLUSION 
In conclusion, the present study shows no relevant effect of meal composition or postprandial 
activity behavior regarding subjective mood and none of the four treatment conditions can be rated 
superior in older adults with a risk phenotype for cardiovascular diseases. Compared to a Western 
diet high-fat meal, a meal composition reflecting the Mediterranean dietary patter seems to be 
beneficial regarding postprandial attention. After the consumption of WD, postprandial resting 
seems to be more beneficial than postprandial walking for optimal cognitive performance. Due to 
its nutrient composition and food items (e.g., higher amount of low-energy/nutrient-dense foods and 
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higher fiber content), MD leads to a stronger and longer lasting feeling of satiety. A selection of 
food items in accordance with the Mediterranean dietary pattern might therefore have a positive 
impact on weight regulation and should be of special importance in overweight-to-obese subjects. 
Future randomized, controlled trials should focus on the investigation of the chronic rather than the 
acute impact of dietary composition and postprandial activity behavior on cognition and emotion to 
further understand mechanisms involved and to develop strategies to attenuate or even prevent 
comorbid neurological conditions in risk subjects. 
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CHAPTER 4: GENERAL DISCUSSION 
The present study examined the acute effects of different meal patterns (Mediterranean-type diet 
meal vs. Western diet high-fat meal) combined with either 30-minutes postprandial moderate 
walking or 30-minutes postprandial resting, on physiological and neuropsychological outcome 
measures in older subjects with increased risk for cardiovascular and neurodegenerative diseases. In 
order to create realistic conditions, the present study, in comparison to other postprandial 
intervention studies in this field of research, followed a holistic approach. Therefore, focused was 
set on the effects of complete meals rather than single nutrients and on a physical activity session 
that can easily be incorporated into everyday situations, especially by rather inactive or physically 
restricted individuals. 
Research suggests that even acute postprandial responses following the consumption of high-
carbohydrate or high-fat meals seem to increase the risk of development of CVDs. In this context, 
postprandial hyperglycemia and hyperlipidemia are described to be major independent risk factors 
triggering subsequent postprandial responses of oxidation, inflammation, and endothelial 
dysfunction (Jiang et al. 2017; Pirillo et al. 2014). Therefore, the development of strategies to 
counteract an excessive increase in plasma glucose and serum triglyceride concentrations after meal 
intake, while considering the summative metabolic response of both carbohydrate and lipids in the 
context of holistic meals, is of physiological relevance. This is particularly the case for individuals 
already at increased risk to develop cardiovascular complications (e.g., individuals with metabolic 
syndrome traits) (Edinburgh et al. 2017; Emerson et al. 2016). 
As expected, both test meals led to a significant increase in serum triglycerides, plasma glucose, and 
serum insulin in the postprandial period, similar to their characteristic nutrient composition (total 
amount of carbohydrate and fat; fatty acid composition). Next to the lower amount of total fat 
(59.4 g vs. 40.1 g) and SFAs (32.0 vs. 5.1 g) in the Mediterranean-type diet meal, its higher amount 
of dietary fiber (14.5 g vs. 4.2 g) might have additionally been responsible for the lower increase in 
postprandial triglycerides observed after this meal type. Especially soluble dietary fiber is described 
to be associated with moderate reductions in postprandial serum triglycerides following the 
consumption of mixed meals (Hannon et al. 2019; Edinburgh et al. 2017; Lopez-Miranda et al. 
2007). Furthermore, soluble dietary fiber has the potential to reduce the postprandial glucose 
absorption rate after the consumption of a high carbohydrate load through delayed gastric emptying 
and altered viscosity properties (Cassidy et al. 2018; Stewart and Zimmer 2018). Therefore, despite 
the higher total amount of carbohydrate in the Mediterranean-type diet meal than in the Western 
diet high-fat meal (133 g vs. 93.7 g), attenuating effects on postprandial glucose and insulin 
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concentrations could have been expected after the Mediterranean-type diet meal, due to its higher 
amount of dietary fiber and lower mono- and disaccharides to polysaccharides ratio (0.96 vs. 0.65). 
However, both, plasma glucose and serum insulin, were higher after the Mediterranean-type diet 
meal than after the Western diet high-fat meal. Since the study protocol did not allow including 
further measuring points in the earlier postprandial period (< 1.5 h postprandial), it remains unclear, 
whether the potential attenuating effects of the complex carbohydrates on plasma glucose and 
serum insulin concentrations occurred during this time frame. Additionally, as observed in the 
present study as well (higher satiety values after the Mediterranean-type diet meal than after the 
Western diet high-fat meal), fiber ingestion induces increased satiety. This might lead to a decrease 
in further energy intake in the case of multiple meal consumption (Tucker and Thomas 2009). 
Therefore, the regular consumption of meals / food items characteristic for the Mediterranean 
dietary pattern might indirectly contribute to attenuated postprandial responses during the course of 
one day, due to their effects on postprandial satiety.  
Glucose is an important brain substrate and neural tissue depends on an adequate glucose supply 
under physiological conditions. Therefore, a habitual diet in accordance with the Mediterranean 
dietary pattern, that induces a low but sustained blood glucose profile and avoids higher glucose 
peaks and, thus, secures optimal glucose delivery to the brain in the fed and fasting states, should be 
most advantageous for the maintenance of cognitive function (Sünram-Lea and Owen 2017; Nilsson 
et al. 2012). It remains unclear, if the higher amount of carbohydrates in the Mediterranean-type 
diet meal was decisive for the significant meal effect (higher overall attention scores in the 
Mediterranean-type diet meal than in the Western diet high-fat meal) in the present trial, or to what 
extent the interaction of different nutrients contributed to the observed effects. 
Impaired insulin sensitivity / insulin resistance as a major characteristic of the metabolic syndrome 
is associated with an exaggerated postprandial glycemic response after meal intake (Ormazabal et 
al. 2018; Edinburgh et al. 2017; Beilby 2004). To evaluate the effect of insulin resistance on 
postprandial glucose and insulin concentrations in the present trial, the homeostasis model 
assessment for insulin resistance (HOMA-IR) was calculated according to Matthews et al., 1985 
(calculation of mean HOMA-IR for the four treatment days for each participant). Postprandial 
glucose and insulin concentrations were compared in dependence on this factor (Matthews et al. 
1985). In the present study, 73% of participants (n = 19) had an HOMA-IR > 2.5, which indicates 
possible insulin resistance. For the remaining 27% of participants (n = 7) the calculations resulted in 
HOMA-IR < 2.5. Figure 4-1 compares the iAUC for plasma glucose and serum insulin 
concentrations for the four treatment groups in dependence on HOMA-IR and shows exaggerated 
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plasma glucose and especially serum insulin concentrations in participants with HOMA-IR > 2.5. 
This confirms the association between insulin resistance and an exaggerated postprandial glycemic 
response, which might have influenced the observed intervention effects on mean glucose and 
insulin concentrations in the postprandial period.  
 
Figure 4-1 Comparison of iAUC for plasma glucose and serum insulin concentrations in all four treatment 
groups in dependence of HOMA-IR. Data show exaggerated plasma glucose and especially serum insulin 
concentrations in participants with HOMA-IR > 2.5. HOMA-IR, Homeostasis model assessment for insulin 
resistance; iAUC, Incremental area under the curve; MD-R, Mediterranean-type diet meal plus postprandial 
resting; MD-W, Mediterranean-type diet meal plus postprandial walking; WD-R, Western diet high-fat meal 
plus postprandial resting; WD-W, Western diet high-fat meal plus postprandial walking. 
Robertson et al., 2002 demonstrated that the extent to which postprandial glucose concentration 
increases during an oral glucose tolerance test seems to be dependent on the amount of dietary fat 
consumed the night before the treatment day. Similarly, postprandial triglyceride concentrations 
after an oral fat tolerance test seem to be higher after a high-carbohydrate, than after a high-fat 
evening meal (Robertson et al. 2002). The impact of previous macronutrient consumption on the 
subsequent metabolism of meal carbohydrate and fat is described as “second meal effect”, which 
has to be taken into consideration while planning postprandial intervention studies (Lambert and 
Parks 2012). To account for this phenomenon in the present trial, participants were asked to 
consume the same evening meal prior to each treatment day, which had to be specifically 
documented as part of the 1-day food diary participants completed on the four pre-treatment days. 
The comparison of mean energy, macronutrient, and dietary fiber intake using one-way ANOVA 
showed no significant differences between the four prior-treatment evening meals (Table 4-1). 
However, especially due to the high intra-individual variance in intake of energy and 
macronutrients (intra-individual coefficient of variation: energy, 23%; fat, 35%; carbohydrate, 28%; 
dietary fiber, 29%; protein, 30%), it cannot be ruled out that the different carbohydrate and fat 
intake during prior evening meals may have influenced postprandial glycemic and lipemic 
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responses on the individual treatment days differently. However, since the fasting concentrations of 
all outcome measures did not differ significantly between the four treatment days (similar starting 
point) it can be assumed that the “second meal effect” was not predominant in the present trial. 
Particularly for studies with the aim to examine the effect of multiple meal intakes (e.g., three meals 
per treatment day) on postprandial metabolism, considering “second meal effect”, as well as the 
consideration of summative metabolic responses of both carbohydrate and lipids, might be of 
particular importance. 
Table 4-1 Energy, macronutrient and dietary fiber intake of participants during prior-treatment evening 
meals1 
 
V 1 V 2 V 3 V 4 P-value2 
Energy (kcal) 590 ± 217 672 ± 263 634 ± 249 634 ± 241 0.691 
Fat (g) 29.2 ± 17.5 32.6 ± 17.7 30.4 ± 18.0 28.3 ± 16.4 0.824 
Carbohydrate (g) 52.3 ± 25.8 57.2 ± 23.6 58.6 ± 25.8 60.1 ± 28.8 0.722 
Dietary fiber (g)   6.4 ± 3.6   7.7 ± 5.1   7.1 ± 3.2   6.9 ± 3.7 0.448 
Protein (g) 26.1 ± 11.3 32.2 ± 18.4 26.0 ± 16.0 28.1 ± 15.6 0.658 
1Data from 1-d food diaries; Shown as mean ± SD, n = 26. 
2Compared using one-way ANOVA. 
Research suggests that glucose and lipid metabolism is influenced by central (brain) and peripheral 
(skeletal muscle, liver, adipose tissue) circadian rhythms (Heden and Kanaley 2019). In this 
context, in metabolically healthy individuals, optimal liver and peripheral insulin sensitivity and 
glycemic control seems to be measurable in the morning hours and worsens through the remainder 
of the day. In individuals with manifested type 2 diabetes, circadian rhythms for these parameters 
seem to be inverted (Heden and Kanaley 2019; Poggiogalle et al. 2018). Therefore, circadian 
rhythms of metabolic parameters might be another important factor which has to be taken into 
consideration while planning dietary intervention trials and evaluating postprandial plasma glucose, 
serum insulin, and serum triglyceride concentrations (Wallis and Gonzalez 2019). In the present 
trial each participant received individual time schedules which provided that all interventions (meal 
intake and walking / resting session), measurements, and blood analyses on each of the four study 
days were carried out at the same time of day. Since each participant served as its own control 
(crossover design), this procedure was the best possible standardization to account for circadian 
rhythm.  
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In contrast to previous postprandial interventions trials examining the effect of postmeal exercise on 
postprandial lipidemia, physical activity in the present trial did not result in mitigating effects on 
serum triglycerides in the postprandial period. On the one hand, the rather short duration and low 
intensity of the walking session might have been responsible for the observed results. On the other 
hand, it is possible that the missing effect of walking on postprandial triglyceride concentrations 
was related to the timing of the exercise session. Research suggests that exercise-induced reductions 
in postprandial triglycerides are more profound in premeal, rather than in postmeal exercise 
(Plaisance and Fisher 2014; Malkova and Gill 2006). Exercise timing might be the reason for the 
observed effects on postprandial glucose and insulin concentrations (exaggerated glycemic response 
after walking compared to resting) as well: Exercise performed in the early postprandial period (0 – 
29 min post-meal intake), seems to result in elevated plasma glucose concentrations due to 
stimulated hepatic glucose output, which rises up to 8-fold, especially when exercise intensity is 
high (> 80% VO2max) (glucose becomes the main fuel). Exercise sessions of low-to-moderate 
intensity (< 80% VO2max) performed during the mid-postprandial period (30 – 120 min post-meal 
intake) preferentially use meal-derived glucose without precipitating counter-regulation (Chacko 
2016). Future postprandial intervention trials might consider planning the exercise session with 
respect to food intake (e.g., postmeal vs. premeal walking), especially for individuals with increased 
CVD risk, in order to optimize the health and therapeutic benefits of exercise (Wallis and Gonzalez 
2019).  
Solomon et al., 2018 indicate that the beneficial effect of physical exercise in glycemic control 
shows inter-individual variability, resulting in some individuals experiencing no plasma glucose 
lowering effects of exercise at all. This hypothesis emphasizes the importance of personalized 
exercise recommendations taking into account different modifiable factors (e.g., exercise-meal 
timing, exercise type, exercise dose), as well as, if feasible, non-controllable factors such as genetic 
disposition and individual practicability (Solomon et al. 2018). Regarding genetic disposition, the 
apolipoprotein E (apoE) genotype might be an important factor predicting the extent of postprandial 
lipidemia, especially in patients with the metabolic syndrome (Cardona et al. 2005). The apoE gene 
is central to the metabolism of LDL and triglycerides and has been associated with increased risk of 
cardiovascular (e.g., coronary heart disease), and neurodegenerative (e.g., AD and dementia) 
diseases (Plourde 2018; Phillips 2017; Haan and Mayeda 2010). The polymorphic protein apoE 
codifies three different alleles (E2, E3, and E4) which account for apoE polymorphism and 
determine six different genotypes (APOE ε2/ε2, APOE ε2/ε3, APOE ε2/ε4, APOE ε3/ε3, APOE 
ε4/ε3, and APOE ε4/ε4) (Marrzoq et al. 2011; Mahley and Rall 2000; Paik et al. 1985). The apoE3 
allele is regarded as the neutral parent isoform and is the most prevalent especially in people of 
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Northern European ancestry. It accounts for no increased risk for cardiovascular or 
neurodegenerative diseases (Haan and Mayeda 2010). In comparison to the apoE3 allele, the apoE4 
allele is associated with higher serum concentrations of total and LDL cholesterol. This seems to be 
the main reason why individuals with apoE4 genotype, even carriers of one apoE4 allele, are at 
increased risk for atherosclerosis and concomitant cardiovascular outcomes; homozygosity seems to 
increase risk even further (Marrzoq et al. 2011). Research suggests that there might be a continuous 
decrease in apoE4 allele prevalence after 60 years of age, especially for homozygotes. This, 
however, might by confounded by the combined mortality from cardiovascular and 
neurodegenerative diseases with increasing age (Heffernan et al. 2016; McKay et al. 2011). The 
apoE2 allele is associated with lower serum concentrations of total and LDL cholesterol compared 
to the apoE3 allele. In a meta-analysis from Zhang et al., 2015, the apoE2 allele is even associated 
with decreased CVD risk (Zhang et al. 2015; Marrzoq et al. 2011). On the other hand, individuals 
with apoE2 genotype show higher serum triglyceride concentrations. Homozygosity (APOE ε2/ε2) 
seems to be a necessary genetic influence that, together with additional genetic or environmental 
risk factors, may lead to the development of type III hyperlipoproteinemia (Utermann et al. 1979). 
The distribution of the apoE genotypes in the present study was APOE ε3/ε3, 85% (n = 22); 
APOE ε4/ε3, 8% (n = 2); APOE ε2/ε3, 4% (n = 1); APOE ε2/ε4; 4% (n = 1). Thus, despite their 
increased CVD risk (compare Table 2-1 Baseline characteristics of participants at high risk of 
cardiovascular disease, in CHAPTER 2: MANUSCRIPT 1), none of the participants had a 
homozygote APOE ε4/ε4 genotype. Only three participants were heterozygote for the apoE4 allele. 
Due to uneven distribution of data, the apoE genotype was not included as covariate / influencing 
factor in the statistical analysis of the present study. However, the observed data put the impact of 
genetic susceptibility on the development of cardiovascular / neurodegenerative outcomes in 
perspective, and emphasize the importance of lifestyle factors in this context. Future intervention 
trials in this field of research might consider prospective apoE-genotyping during screening analysis 
in order to be able to recruit an equal number of APOE ε3/ε3, APOE ε4/ε3, and APOE ε4/ε4 
participants. This would allow determining the effects of meal composition and physical activity on 
postprandial events in dependence on apoE genotype.  
In the present study, the postprandial rise in serum triglycerides, plasma glucose, and serum insulin 
concentrations did not trigger a postprandial oxidative stress response and concomitant endothelial 
dysfunction, which would have been expected due to current model ideas (Wallace et al. 2010). 
Next to oxLDL, additional biomarkers would have been warranted to further elucidate the 
postprandial oxidative stress response. Since oxidative stress is difficult to measure, evaluation 
based on more than one criterion might be reasonable, whereby giving an overall index of redox 
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status should be focused in future intervention trials (Marrocco et al. 2017). Due to scheduling 
reasons, additional measurements which would have evaluated endothelial function more 
specifically (e.g., flow mediated dilatation of the brachial artery), could not be included in the 
present study. However, this might be necessary to consider in future similar intervention trials, to 
be able to fully evaluate the matters of endothelial dysfunction in the postprandial period (Al-Qaisi 
et al. 2008).  
Independent of nutrient composition, both high-energy, high-fat meal types triggered a transient rise 
in postprandial IL-6 concentrations over time. Since IL-6 did not reach baseline concentration at 
4.5 h postprandially, it can be hypothesized, that the stimulus of meal consumption was high 
enough to trigger a postprandial low-grade inflammatory response. Additional time points in the 
later postprandial period (4 – 8 h postprandially) would have been necessary to further examine the 
impact of the test meals on this parameter. Current research suggests that chronic low-grade 
inflammation is associated with altered brain signaling patterns affecting cognition. Furthermore, it 
seems to interact with neurotransmitters and neurocircuits to influence the risk for depression. This 
might be one reason why different chronic diseases (e.g., diabetes, CVD) are characterized by 
increased risk for depressive disorders (Felger 2019; Amodeo et al. 2017). Interactions between 
immune and metabolic processes are known to be evolutionarily conserved. Furthermore, scientific 
evidence regarding the complex immunometabolic signaling networks and cellular and molecular 
events involved is constantly emerging (Hotamisligil 2017a, 2017b). Therefore, future intervention 
trials might shift the focus from analysis of proinflammatory cytokines in the blood stream and the 
analysis of gene-expression of these parameters; additionally measuring the activation of 
macrophages or other innate immune cells, which are known to participate in the process, might be 
reasonable (Hotamisligil 2017a, 2017b). In the present study, higher IL-6 concentrations could be 
observed after walking compared to resting, which might have been due to the skeletal muscle 
release of IL-6 as an anti-inflammatory myokine. Even though acute activity sessions already seem 
to exert anti-inflammatory effects, the regular engagement in physical activity needs to be 
recommended to optimally benefit regarding the prevention and treatment of cardiovascular and 
neurodegenerative diseases (Phillips and Fahimi 2018; Gleeson et al. 2011; Dinas et al. 2011).  
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Conclusion 
The present trial examined the effects of meal composition and physical activity on physiological 
and neuropsychological outcome measures in the postprandial period. In this context, the study 
followed a holistic approach (effects of meals rather than single nutrients) and included a physical 
activity session that can easily be incorporated into everyday situations. Regarding the effect of 
meal composition alone, the Mediterranean-type diet meal resulted in reduced postprandial 
triglyceride and NEFA concentrations compared to the Western diet high-fat meal. Furthermore, the 
Mediterranean-type diet meal led to better overall attention scores in the postprandial period as well 
as increased satiety. Contrary to our hypotheses, moderate walking in the postprandial period, as 
compared to remaining sedentary, did neither result in attenuated postprandial events nor in 
increased postprandial attention or a better subjective mood. Overall, in older adults at increased 
risk for cardiovascular and neurodegenerative diseases, none of the four treatment conditions 
(Western diet high-fat meal plus postprandial walking; Western diet high-fat meal plus postprandial 
resting; Mediterranean-type diet meal plus postprandial walking; Mediterranean-type diet meal plus 
postprandial resting) can be particularly recommended to optimally reduce postprandial metabolic, 
inflammatory, endothelial and oxidative events, and to improve postprandial attention and mood. 
However, due to the steady rise in obesity and metabolic syndrome in recent years, the need for 
targeted dietary and lifestyle strategies for primary and secondary prevention of concomitant 
cardiovascular and neurodegenerative complications is constantly increasing. Therefore, further 
hypothesis-driven postprandial intervention trials reflecting realistic lifestyle conditions are 
warranted in order to be able to further develop scientifically based prevention recommendations in 
the long term.  
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SUMMARY 
The postprandial state is a dynamic period of metabolic processes that occur following the digestion 
and absorption of a meal. Current research suggests that a chronic oversupply of macronutrients and 
total energy and the resulting prolonged and exaggerated postprandial metabolic events (glycemia, 
insulinemia, and lipidemia) that repeat multiple times each day, lead to a short-term oxidative 
imbalance, a status referred to as postprandial oxidative stress. This status is further associated with 
low-grade inflammation and low-grade endothelial dysfunction. Altogether, these processes may 
increase the susceptibility to the development of cardiovascular diseases (CVD) in the long term. 
Therefore, attenuating the postprandial stress response and its associated events through specific 
nutritional and lifestyle interventions seems to be a promising and important approach, which is 
particularly relevant in individuals already at increased risk to develop cardiovascular or 
neurodegenerative complications (e.g., individuals with metabolic syndrome). 
The present study followed a holistic approach and examined the effects of meal composition and 
moderate physical activity on postprandial events in 26 older subjects with increased risk for the 
development of cardiovascular and neurodegenerative diseases (age 70 ± 5 y; BMI 30.3 ± 
2.3 kg/m2). In a randomized crossover design, two high-energy meals reflecting different dietary 
patterns (Mediterranean-type diet meal, MD; Western diet high-fat meal, WD) were combined with 
either 30-minutes of postprandial moderate walking or 30-minutes of postprandial resting. Next to 
metabolic outcomes (serum triglycerides, serum non-esterified fatty acids, plasma glucose, serum 
insulin) the present study included selected oxidative (plasma oxidized low density lipoprotein), 
endothelial (plasma soluble intercellular adhesion molecule-1, plasma soluble vascular cell 
adhesion molecule-1, serum soluble endothelial selectin), and inflammatory (plasma interleukin-6) 
parameters, as well as blood pressure and heart rate. Additional focus was set on 
neuropsychological parameters (attention, mood, and the feeling of hunger and satiety) and plasma 
cortisol concentration. All outcome measures were analyzed at fasting and 1.5 h, 3.0 h, and 4.5 h 
postprandially.  
The study tested the following hypotheses: i) a MD generates a lower postprandial response than a 
WD; ii) moderate walking in the postprandial period as compared to remaining sedentary, results in 
attenuated postprandial events; iii) a MD generates higher postprandial satiety, postprandial 
attention, and a better subjective mood than a WD; and iv) moderate walking in the postprandial 
period as compared to remaining sedentary, results in increased postprandial attention and a better 
subjective mood.  
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In comparison to the WD, the MD was associated with superior effects on several postprandial 
parameters (e.g., lower serum triglyceride concentration). Contrary to our hypothesis, data revealed 
no beneficial effects of walking over resting. Furthermore, meal composition had no relevant 
impact on attention and mood. However, after the WD, resting instead of walking resulted in 
increased postprandial attention. Additionally, the MD led to a stronger and longer-lasting feeling 
of satiety, compared to the WD.  
Overall, none of the four treatment conditions could be particularly recommended to optimally 
reduce postprandial metabolic, oxidative, inflammatory, and endothelial events, and to improve 
postprandial attention and mood. However, due to the steady rise in obesity and metabolic 
syndrome in recent years, the need for targeted dietary and lifestyle strategies for primary and 
secondary prevention of concomitant cardiovascular and neurodegenerative complications is 
constantly increasing. Therefore, further hypothesis-driven postprandial intervention trials reflecting 
realistic lifestyle conditions are warranted in order to be able to further develop scientifically based 
prevention recommendations in the long term.  
  
106  ZUSAMMENFASSUNG 
 
 
ZUSAMMENFASSUNG 
Der postprandiale Stoffwechsel beschreibt die Gesamtheit aller dynamischen Stoffwechselprozesse, 
welche im Anschluss an den Mahlzeitenverzehr im Organismus zu verzeichnen sind. Aktuelle 
Forschungsergebnisse deuten darauf hin, dass ein chronisches Überangebot and Makronährstoffen, 
bedingt durch den regelmäßigen Verzehr energiereicher Mahlzeiten, zu verstärkten metabolischen 
Reaktionen (längere Dauer, höheres Ausmaß) führt (Hyperglykämie, Hyperinsulinämie, 
Hyperlipidämie), welche in einer geringgradigen oxidativen Stressreaktion resultieren. Dieser 
Zustand wird als postprandialer oxidativer Stress bezeichnet. Der postprandiale oxidative Stress 
wird weiterhin mit einer geringgradigen postprandialen Inflammation und einer geringgradigen 
postprandialen endothelialen Dysfunktion assoziiert. In ihrer Gesamtheit scheinen diese Prozesse 
langfristig mit einem erhöhten Risiko für die Entwicklung kardiovaskulärer Erkrankungen (CVD) 
einher zu gehen. Die Abschwächung der postprandialen Stoffwechselreaktionen über spezifische 
Ernährungs- und Lebensstilmaßnahmen stellt einen vielversprechenden und wichtigen 
Forschungsansatz dar, welcher insbesondere für Personen mit erhöhtem Risiko für kardiovaskuläre 
und neurodegenerativer Erkrankungen (z.B. Personen mit Metabolischem Syndrom) eine hohe 
Relevanz hat. 
Die vorliegende Studie verfolgte einen ganzheitlichen Ansatz und untersuchte die Effekte von 
Mahlzeitenzusammensetzung und moderater Bewegung auf den postprandialen Stoffwechsel, bei 
26 älteren Personen mit erhöhtem Risiko für kardiovaskuläre und neurodegenerative Erkrankungen 
(70 ± 5 Jahre; BMI 30,3 ± 2,3 kg/m2). Im Rahmen eines randomisierten crossover Designs wurden 
zwei energiereiche Mahlzeiten, welche in ihrer Zusammensetzung an das Mediterrane- bzw. das 
Westliche Ernährungsmuster angelehnt waren (Mediterranean-type diet meal, MD; Western-diet 
high fat meal, WD), mit einer 30-minütigen postprandialen Walking-Einheit, oder einer 30-
minütigen postprandialen Ruhephase kombiniert. Die Zielgrößen der Studie umfassten 
metabolische (Serum-Triglyceride, Serum-Freie Fettsäuren und Serum-Insulin, Plasma-Glucose), 
oxidative (oxidiertes low density lipoprotein im Plasma), inflammatorische (Interleukin-6 im 
Plasma) und endotheliale (soluble intercellular adhesion molecule-1 und soluble vascular cell 
adhesion molecule-1 im Plasma, soluble endothelial selectin im Serum) Parameter, sowie Blutdruck 
und Herzfrequenz. Zudem wurden neuropsychologische Parameter (Aufmerksamkeit, 
Befindlichkeit, Sättigungsempfinden) und die Plasma Cortisol Konzentration erfasst. Die folgenden 
Hypothesen wurden der Studie zugrunde gelegt: i) eine MD resultiert in einer abgeschwächten 
postprandialen Stoffwechselantwort im Vergleich zu einer WD; ii) eine postprandiale Walking-
Einheit resultiert in einer abgeschwächten postprandialen Stoffwechselantwort im Vergleich zu 
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einer postprandialen Ruhephase; iii) eine MD resultiert in einem erhöhten Sättigungsempfinden und 
einer verbesserten Aufmerksamkeit und Stimmung im Vergleich zu einer WD; und iv) eine 
postprandiale Walking-Einheit resultiert in einer verbesserten postprandialen Aufmerksamkeit und 
Stimmung im Vergleich zu einer postprandialen Ruhephase. Alle Zielgrößen wurden nüchtern 
erfasst, sowie 1,5 h, 3,0 h und 4,5 h postprandial. 
Im Vergleich zur WD zeigte die MD einen günstigeren Einfluss auf den postprandialen Verlauf 
einzelner Parameter (z.B. niedrigere Triglycerid-Konzentration im Serum). Entgegen unserer 
Erwartungen zeigte das moderate Walking keine vorteilhafteren Effekte im Vergleich zur 
Ruhephase. Weiterhin nahm die Mahlzeitenzusammensetzung keinen relevanten Einfluss auf 
Aufmerksamkeit und Stimmung in der postprandialen Phase. Nach dem Verzehr der WD wirkte 
sich die Ruhephase im Vergleich zur Walking-Einheit verbessernd auf die postprandiale 
Aufmerksamkeit aus. Darüber hinaus führte der Verzehr der MD zu einem stärkeren und länger 
anhaltenden Sättigungsempfinden. 
Zusammenfassend ist festzuhalten, dass keine der vier Interventionsgruppen besonders empfohlen 
werden kann, um postprandiale metabolische, oxidative, inflammatorische und endotheliale 
Ereignisse optimal zu reduzieren und um Aufmerksamkeit und Stimmung in der postprandialen 
Phase zu verbessern. Aufgrund des stetigen Anstiegs von Adipositas und dem Metabolischen 
Syndrom in der heutigen Gesellschaft steigt jedoch der Bedarf an gezielten Ernährungs- und 
Lebensstilmaßnahmen zur Primär- und Sekundärprävention kardiovaskulärer und 
neurodegenerativer Ereignisse weiterhin an. Nicht zuletzt deshalb sind weitere realitätsnahe 
postprandiale Interventionsstudien unabdingbar, um langfristig Präventionsempfehlungen 
wissenschaftlich fundiert weiterentwickeln zu können.  
 
